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Abstract
Investigators often evaluate treatment effects by considering settings in which all individuals
are assigned a treatment of interest, assuming that an unlimited number of treatment units
are available. However, many real-life treatments are of limited supply and cannot be
provided to all individuals in the population. For example, patients on the liver transplant
waiting list cannot be assigned a liver transplant immediately at the time they reach highest
priority because a suitable organ is not likely to be immediately available. In these cases,
investigators may still be interested in the effects of treatment strategies in which a finite
number of organs are available at a given time, that is, treatment regimes that satisfy
resource constraints. Here, we describe an estimand that can be used to define causal
effects of treatment strategies that satisfy resource constraints: proportionally-representative
interventions for limited resources. We derive a simple class of inverse probability weighted
estimators, and apply one such estimator to evaluate the effect of restricting or expanding
utilization of ‘increased risk’ liver organs to treat patients with end-stage liver disease. Our
method is designed to evaluate policy-relevant interventions in the setting of finite treatment
resources.
∗Contact information for corresponding author:
Aaron L. Sarvet, Department of Epidemiology, Harvard T. H. Chan School of Public Health, USA. asarvet@
g.harvard.edu
ar
X
iv
:2
00
2.
11
84
6v
2 
 [s
tat
.M
E]
  2
8 F
eb
 20
20
1. Introduction
The average treatment effect is consistently estimated with data from an ideal random-
ized trial. This effect is identified because the expected outcome in the treatment arm is
identical to the expected potential outcome had everyone been provided treatment (and
likewise for control). Observational studies can provide estimates with the same interpreta-
tion, when the data are used to emulate a randomized trial [1, 2]. Results of these studies
are often used to justify decisions by policy makers interested in population outcomes under
hypothetical policies. However, these results are not directly relevant when treatment is not
available for everyone in the target population, for example due to practical limitations on
treatment resources.
Limitations on treatment resources represent important conditions in nearly every con-
ceivable health policy setting. Consider studies that aim to assess the effects of liberal vs.
conservative strategies for surgical blood transfusion [3], or of care reception at hospitals with
high vs. low procedural volume [4]. The corresponding randomized trial implicitly considers
infeasible policies, in which: all patients follow a liberal transfusion strategy; or all patients
receive the procedure at a hospital with high procedural volume. Neither study considers
policies that are implementable (due to lack of sufficient blood supply, or surgeons), yet their
results form the basis of medical guidelines and national policies. For example, implementing
an apparently favorable policy may lead to unexpected adverse outcomes due to increases
in waiting times that are unavoidable in limited resource settings. These mechanisms are
not appreciated by conventional methods.
Studies aiming to inform real-world policy-making should consider treatment strategies
that are compatible with real-world resource constraints. We describe a new class of esti-
mands that is relevant for policy makers who are interested in causal questions in settings
where treatment resources are limited. We refer to estimands of this class as expected po-
tential outcomes under proportionally-representative interventions that constrain treatment
resources.. We present an inverse probability weighting estimator for these estimands that
is easy to implement with standard statistical software. To fix ideas and facilitate their
introduction, the main text presents the observed data structure, identification conditions,
and estimation strategies in the following common setting: patients are waiting to receive a
single dose of one of two treatments types, and policy makers are considering eliminating the
suspected inferior treatment type, versus continuing to use both treatment types as usual
(i.e. no policy change). Such settings are common in medicine and public health, where
e.g. patients are faced with decisions between treatment types with limited supply; from the
patient’s perspective, the decision is reducible to choosing between a plan of accepting the
first treatment option that becomes available, and a plan of waiting for the suspected supe-
rior treatment option. For example, a patient with non-emergency indications for coronary
artery bypass graft surgery might seek recommendations for choosing between procedure
reception as soon as possible (including possibly at their local area hospital) or waiting to
undergoing the procedure at a regional center of excellence.
In general, proportionally-representative interventions permit consideration of settings
where treatment resources are constrained to any hypothetical level. For example, investi-
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gators may be interested in a policy where utilization of the suspected superior treatment
type is doubled (relative to extant levels), possibly corresponding to increased investment
in the superior treatment resource supply. Therefore, we have included extensions to set-
tings in which resources are arbitrarily constrained. We also present extensions to censoring,
provide proofs of key results, and further discuss relationships between these new limited
resource estimands and classical estimands. Finally we illustrate the method by estimating
the effects of different policies for liver transplantation, where treatment resource limitations
are severe.
2. Data Structure
We consider a study in which n individuals are followed for k ∈ {0, 1, . . . , K} equally
spaced discrete time intervals. The individuals i ∈ {1, . . . , n} are independent and identically
distributed at baseline, and thus we generally omit the i subscript on the random variables.
In each interval k, an individual is a candidate for receiving treatments Bk and Hk, where
Bk is an indicator for receiving the suspected superior treatment (e.g. a “high-quality” organ
transplant) and Hk is an indicator for receiving the suspected inferior treatment (e.g. a “low-
quality” organ transplant). Let Lk be a vector of the individual’s covariates with support
Lk and Yk a binary survival outcome by the end of interval k.
We use over-lines (e.g. Bk) to indicate the history of variables, underlines (e.g. Bk) to
indicate the future trajectory of variables, and superscripts to indicate potential outcomes
under some policy, e.g. Y gzk is the potential outcome in interval k under policy gz. We
supplement superscripts with the ‘plus’ symbol (+) to differentiate the natural values of
treatment under some policy (e.g. Bgzk ) from the values that treatment takes immediately
following intervention on that variable under that policy (e.g. Bgz+k ). This is coherent with
the notation in section 5.1 of Richardson and Robins, 2013 [5] and see Young et. al (2014)
[6] for a thorough review of the distinction between natural and post-intervention treatment
variables. We define a topological order within each interval as
(
Lk, Bk, Hk, Yk
)
.
By definition, all individuals are alive and untreated in interval 0, so B0 = H0 = Y0 = 0,
L0 is equal to the empty set ∅, and individuals may only possibly receive a single treatment,
such that if Bk = 1 then Hk = Bk+1 = 0, and if Hk = 1 then Bk+1 = Hk+1 = 0. For
notational convenience, we define the indicator functions Rk = I{Yk−1 = Hk−1 = Bk−1 = 0}
and Sk = I{Bk = Yk−1 = Hk−1 = 0}. Thus, by the above definitions, Rk and Sk indicate
treatment eligibility (i.e. “being at risk” of receiving treatment) in an interval, for suspected
superior and inferior treatments, respectively. It follows immediately that R1 = 1.
3. Proportionally-representative interventions
In this section, we describe policy-relevant regimes gz, within the class of proportionally-
representative interventions. As elaborated below, proportionally-representative interven-
tions are stochastic interventions defined by observed conditional treatment densities, and by
a priori user-specified resource constraints. To fix ideas, we present specific policy-relevant
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regimes g1 and g0, where g1 corresponds to a policy of abolishing the suspected-inferior
treatment, and g0 corresponds to a policy of no intervention.
First, we define the treatment resource constraints that motivate the policy-relevant
regimes. Let qgzk and m
gz
k , respectively, be the multiplicative factors by which the population
utilization of superior and inferior treatment units, respectively, are changed (relative to the
unintervened world) in interval k under regime gz. For regime g1:
qg1k = 1 (1)
mg1k = 0, (2)
and for regime g0:
qg1k = 1 (3)
mg1k = 1, (4)
for all k ∈ {1, . . . , K}.
In words, the constraints are specified such that: 1) the population utilization of sus-
pected superior treatment units used under both regimes g1 and g0 in interval k (q
g1
k ×P (Bk =
1) and qg0k × P (Bk = 1)) are equal to the number of superior treatment units actually used
in the absence of intervention (P (Bk = 1)); and 2) the population utilization of suspected
inferior treatment units used under regime g1 in interval k (m
g1
k × P (Hk = 1)) is set to 0
(corresponding to a policy in which the use of such treatment units is abolished), whereas
the number of such units used under regime g0 in interval k (m
g0
k ×P (Hk = 1)) is maintained
equal to the number of inferior treatment units actually used in the absence of intervention
(P (Hk = 1), corresponding to a policy of no intervention).
For notational convenience, we re-express the constraints for regime g1 as
P (Bg1+k = 1) = P (Bk = 1) (5)
P (Hg1+k = 1) = 0, (6)
and for regime g0 as
P (Bg0+k = 1) = P (Bk = 1) (7)
P (Hg0+k = 1) = P (Hk = 1), (8)
for all k ∈ {1, . . . , K}.
In general, we define regime gz to be a stochastic intervention on Hk and Bk for all
k ∈ {1, ..., K}, where z ∈ {0, 1} indicates regime, such that intervention distributions are
defined as follows
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fBgz+k |Rgz+k ,L
gz
k
(1 | Rk, Lk) = αk(z)× fBk|Rk,Lk(1 | Rk, Lk) (9)
fHgz+k |Sgz+k ,L
gz
k
(1 | Sk, Lk) = βk(z)× fHk|Sk,Lk(1 | Sk, Lk), (10)
with probability 1, where fBk|Rk,Lk(· | ·) and fBgz+k |Rgz+k ,Lgzk (· | ·) are the probability
density functions for receiving the suspected superior treatment unit under the observed
data generating mechanism and under regime gz, respectively, and likewise for fHk|Sk,Lk(· | ·)
and fHgz+k |Sgz+k ,L
gz
k
(· | ·), with respect to the suspected inferior treatment. Note that Rgz+k =
I{Y gzk−1 = H
gz+
k−1 = B
gz+
k−1 = 0} and likewise Sgz+k are defined in terms of post-intervention
(as opposed to natural) treatment variables. Moreover, define αk(z) and βk(z) as regime
z-specific scaling functions that satisfy certain resource constraints,
αk(z) =
P (Bgz+k = 1)
P (Bgzk = 1)
, (11)
βk(z) =
P (Hgz+k = 1)
P (Hgzk = 1)
, (12)
for all k ∈ {1, . . . , K}. By plugging in the resource constraints defined by expressions
(5)-(8), we have that
αk(1) =
P (Bk = 1)
P (Bg1k = 1)
(13)
βk(1) = 0, (14)
and
αk(0) =
P (Bk = 1)
P (Bg0k = 1)
(15)
βk(0) =
P (Hk = 1)
P (Hg0k = 1)
, (16)
where we deliberately use the natural values of treatment, Hgzk and B
gz
k . We show in Lemma
1 of Appendix A that αk(z) and βk(z) will always take some value between 0 an 1 under
the constraints in (5)-(8).
We remind the reader that regime gz involves proportionally-representative interventions
on the conditional likelihoods of treatment reception. Specifically regime gz assigns an eli-
gible individual treatment in interval k probability equal to αk(z)× P (Bk = 1 | Rk, that is,
with probability equal to some constant (αk(z)) times the factual likelihood of that individual
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receiving that treatment given their covariate and treatment history. The proportionally-
representative interventions are stochastic, because they randomly assign treatment accord-
ing to some pre-specified, non-degenerate distribution [6]. They are representative [6], be-
cause this distribution is chosen, for each individual, to be a function of the treatment
distribution of the observed data generating mechanism, conditional on that individual’s
treatment and confounder history (e.g. fBk|Rk,Lk(· | ·)). Thus, proportionally-representative
interventions are considered to be dynamic interventions, with respect to treatment and
confounder history, in that the treatment assignment rule for each individual is a function
of these variables. Proportionally-representative interventions constrain resources because
αk(z) and βk(z) are chosen specifically so that marginal treatment utilization will be equal
in expectation to some value consistent with a set of pre-specified treatment limitations,
as in expressions (5) and (7). In Appendix B we prove that the resource constraints are
satisfied under these interventions.
The above expressions represent a subset of proportionally-representative interventions
for limited resources: interventions in which treatments are either abolished or constrained
such that marginal treatment utilization in the intervened world will be equal in expectation
to that in the unintervened world. In general, proportionally-representative interventions
could be employed to constrain resource utilization to any arbitrary level, including levels
greater than those in the unintervened world, and we provide flexible definitions of these
regimes in Appendix A. We also show in Appendix C that, when all treatment types are
either abolished, or are assumed unlimited and provided to every individual with a particular
covariate and treatment history, then – for all covariate and treatment histories and all time
points – the joint counterfactual treatment density under such a regime is exactly equal to
the analogous density under a particular traditional dynamic deterministic regime. This
equivalence demonstrates that any dynamic deterministic regime can be understood as a
special (and often unrealistic) case of a proportionally representative intervention, in which
treatment resources are either abolished or assumed to be practically unlimited.
4. Identification:
To identify expected potential outcomes under regime gz, E[Y gzk ], for all k ∈ {1, . . . , K}
from observed data distributions, the following identification conditions are sufficient:
4.1. Exchangeability 1
Y gzt ⊥ I(Bgzt = bt) | Lgzt = lt, Y gzt−1 = 0, Hgzt−1 = ht−1, Bgzt−1 = bt−1 (17)
for {bt, lt, ht−1 | P (Bgz+t = bt, Lgzt = lt, Y gzt−1 = 0, Hgz+t−1 = ht−1) > 0}, t ∈ {1, . . . , k}, and
Y gzt ⊥ I(Hgzt = ht) | Bgzt = bt, Lgzt = lt, Y gzt−1 = 0, Hgzt−1 = ht−1, (18)
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for {ht, bt, lt | P (Hgz+t = ht, Bgz+t = bt, Lgzt = lt, Y gzt−1 = 0) > 0}, t ∈ {1, . . . , k}.
These sequential exchangeability conditions are implied by the standard “no unmeasured
confounding” for the outcomes Y t, with respect to past treatment.
4.2. Exchangeability 2
Bgzt ⊥ I(Bgzt−1 = bt−1) | Lgzt−1 = lt−1, Y gzt−2 = 0, Hgzt−2 = ht−2, Bgzt−2 = bt−2, (19)
for {bt−1, lt−1, ht−2 | P (Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = 0, Hgz+t−2 = ht−2) > 0}, t ∈
{1, . . . , k},
and
Bgzt ⊥ I(Hgzt−1 = ht−1) | Bgzt−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = 0, Hgzt−2 = ht−2, (20)
for {ht−1, bt−1, lt−1 | P (Hgz+t−1 = ht−1, Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = 0) > 0}, t ∈
{1, . . . , k},
These exchangeability conditions are implied by the assumption of “no unmeasured con-
founding” for natural treatments Bgzt , with respect to past treatment, as in Young et al.
[6]. The reason why we do not need analogous exchangeability conditions for Hgzt is the
specific regimes under consideration, g1 and g0, specified by the constraints of expressions
(5)-(8). For proportionally representative interventions that arbitrarily constrain resources,
additional exchangeability conditions for Hgzt are needed, as outlined in Appendix A.
While we have noted that the above conditions are implied by standard “no unmeasured
confounding” conditions, Exchangeabilities 1 and 2 are weaker because they are restricted
to treatment levels within covariate and treatment histories that are plausible under the
regime of interest, gz; Exchangeabilities 1 and 2 can together be interpreted as a time-varying
generalization to the conditional exchangeability condition C2 in Haneuse and Rotnitzky,
2013 [7], who considered feasible interventions on an individual’s surgical operating time that
depended on that individual’s operating time they would have received under the observed
data generating mechanism. Haneuse and Rotnitzky noted that the usual “no unmeasured
confounding” assumptions imply that any individual could have received a surgical operating
time of any of the lengths considered within a particular covariate level, and that these
surgical operating time were as good as randomized within this group. This assumption
is unreasonable when some ranges of operating times are infeasible for a subpopulation
defined by the particular covariate level. in the context of the applied example of section
6, we highlight why the stronger, traditional exchangeability condition is unreasonable in
many settings with limited resources.
Furthermore, note that Exchangeability 1 and Exchangeability 2 together are implied
by the Exchangeability condition of Theorem 31 in Richardson and Robins, 2013 [5]. Thus,
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Exchangeabilities 1 and 2 are easy to check in a Single World Intervention Template (SWIT)
for conditional d-separations between the nodes corresponding to Y gzk and past natural
treatment variables Bgzk and H
gz
k . We provide an example SWIT in which these hold in
Figure 1.
4.3. Consistency
if Bt = B
gz+
t and H t = H
gz+
t
then Yt = Y
gz
t , Lt+1 = L
gz
t+1, and Bt+1 = B
gz
t+1, and: (21)
if H t = H
gz+
t and Bt+1 = B
gz+
t+1
then Ht+1 = H
gz
t+1, (22)
for all t ∈ {0, . . . , k}. The consistency assumptions state that if an individual whose
observed treatment history up until some interval equals their assigned treatment history
under regime gz, then the values of all future observed variables that are non-descendants
of future treatments (minimally, the immediately subsequent outcome, covariates, and the
natural value of subsequent treatment) are equal to the value they would naturally take had
that individual actually followed regime gz.
4.4. Positivity
fRgz+t ,L
gz
t
(1, Lt) > 0 and fBgz+t |Rgz+t ,L
gz
t
(Bt | 1, Lt) > 0 =⇒
fBt|Rt,Lt(Bt | 1, Lt) > 0, w.p.1, (23)
and
fSgz+t ,L
gz
t
(1, Lt) > 0 and fHgz+t |Sgz+t ,L
gz
t
(Ht | 1, Lt) > 0 =⇒
fHt|Sk,Lt(Ht | 1, Lt) > 0, w.p.1, (24)
for all t ∈ {1, . . . , t}. That is, if there exists in interval t some treatment-eligible individu-
als with covariate history lt who are assigned treatment bt under regime gz, then there must
exist individuals with the same covariate and treatment history under the observed data
generating mechanism. Note that most proportionally-representative interventions guaran-
tee this positivity condition, (23), since by definition of the regimes in expressions (9) and
(10), fBt|Rt,Lt(· | ·) = 0 implies fBgz+t |Rgzt ,Lgzt (· | ·) = 0, and therefore lack of positivity would
contradict the definition of the regimes.
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4.5. Identification formulae
When conditions hold, we can identify E(Y gzK ) from the non-extended g-formula of Robins
(1986) for YK , f
gz
YK
(1),
f gzYK (1) =
∑
lK
∑
hK
∑
bK
K∑
k=1
P (Yk = 1 | Hk = hk, Bk = bk, Lk = lk, Yk−1 = 0) (25)
×
k∏
j=1
{
f
Hgz+j |B
gz+
j ,L
gz
j ,Y
gz
j−1,H
gz+
j−1
(hj | bj, lj, 0, hj−1)
× f
Bgz+j |L
gz
j ,Y
gz
j−1,H
gz+
j−1 ,B
gz+
j−1
(bj | lj, 0, hj−1, bj−1)
× P (Lj = lj | Yj−1 = 0, Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1)
× P (Yj−1 = 0 | Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1, Yj−2 = 0)
}
,
where
f
Bgz+j |L
gz
j ,Y
gz
j−1,H
gz+
j−1 ,B
gz+
j−1
(bj | lj, 0, hj−1, bj−1) =
(
αj(z)× fBj |Lj ,Yj−1,Hj−1,Bj−1(1 | lj, 0, hj−1, bj−1)
)bj
×
(
1− αj(z)× fBj |Lj ,Yj−1,Hj−1,Bj−1(1 | lj, 0, hj−1, bj−1)
)1−bj
.
and
f
Hgz+j |B
gz+
j ,L
gz
j ,Y
gz
j−1,H
gz+
j−1
(hj | bj, lj, 0, hj−1) =
(
βj(z)× fHj |Bj ,Lj ,Yj−1,Hj−1(1 | bj, lj, 0, hj−1)
)hj
×
(
1− βj(z)× fHj |Bj ,Lj ,Yj−1,Hj−1(1 | bj, lj, 0, hj−1)
)1−hj
.
Since all individuals are alive and untreated in interval 0, regardless of regime, we can
trivially apply the consistency condition in expression (5) to find that α1(z) is identified
by
P (Bgz+1 =1)
P (B1=1)
. Thus αj(z) and βj−1(z) are identified recursively for j ∈ {2, . . . , K + 1},
respectively, so that
αj(z) =
P (Bgz+j = 1)
f gzBj(1)
and
βj−1(z) =
P (Hgz+j−1 = 1)
f gzHj−1(1)
,
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where P (Bgz+j = 1) and P (H
gz+
j−1 = 1) are determined by the constraints, and f
gz
Bj
(1) is
the non-extended g-formula for Bj,
f gzBj(1) =
∑
lj
P (Bj = 1 | Lj = lj, Rj = 1) (26)
×
j∏
m=1
{
P (Lm = lm | Rm = 1, Lm−1 = lm−1)
× P (Ym−1 = 0 | Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
× (1− βm−1(z)× fHm−1|Sm−1,Lm−1(1 | 1, lm−1))
× (1− αm−1(z)× fBm−1|Rm−1,Lm−1(1 | 1, lm−1))},
and f gzHj(1) is the non-extended g-formula for Hj,
f gzHj(1) =
∑
lj
P (Hj = 1 | Lj = lj, Sj = 1) (27)
×
j∏
m=1
{(
1− αm(z)× fBm|Rm,Lm(1 | 1, lm)
)
× P (Lm = lm | Rm = 1, Lm−1 = lm−1)
× P (Ym−1 = 0 | Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
× (1− βm−1(z)× fHm−1|Sm−1,Lm−1(1 | 1, lm−1))}.
Note that the sets of densities in f gzBj(1) and f
gz
Hj
(1), excluding the observed conditional
densities of receiving the suspected superior, and suspected inferior treatment resource in
interval j, that is, P (Bj = 1 | Lj = lj, Rj = 1), and P (Hj = 1 | Lj = lj, Sj = 1), respectively,
are strict subsets of the set of densities in f gzYK (1). As such, f
gz
Bj
(1) and f gzHj(1) are simply
truncated versions of the same g-formula as f gzYK (1) that identify distributions of different
outcomes – the natural values of treatment – at time j.
Furthermore, note that when z = 0, P (Bg0+1 = 1) = P (B1 = 1), then α1(0) = 1.
Thus, f g0H1(1) = P (H1). Since P (H
g0+
1 = 1) = P (H1 = 1), then β1(0) = 1, as well. Since
P (Bg0+k = 1) = P (Bk = 1) and P (H
g0+
k = 1) = P (Hk = 1) for all k ∈ {1, . . . , K}, as in
the definitions of the constraints in (7) and (8), arguing iteratively, then αk(0) = 1 and
βk(0) = 1 for all k ∈ {1, . . . , K}, so that E[Y g0K ] = f gzYK (1) = E[YK ].
We provide a proof of the above identification results in the more general case where
treatment resources are arbitrarily constrained and subjects may be lost to follow-up, in
Appendix D.
4.5.1. Alternative representations of the g-formula
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The g-formula (25) may be expressed in many ways, and its representation is arbitrary
when computation is non-parametric. However, alternative representation will impact com-
putational complexity and statistical properties when parametric estimation is chosen in
high-dimensional settings with finite samples, as is often the case. A particular representa-
tion naturally motivates a class of inverse probability weighted (IPW) estimators that are
easily computed with off-the-shelf software. Therefore we describe equivalent representations
of g-formula in (25) below, where we define V to be any subset of L1, including possibly the
emptyset, ∅.
f gzYK (1) =
∑
v
K∑
k=1
λgzY,k(v)
k−1∏
j=1
[1− λgzY,j(v)]f(v), (28)
where
λgzY,k(V ) =
E
[
Yk(1− Yk−1)W gzH,kW gzB,k | V
]
E
[
(1− Yk−1)W gzH,kW gzB,k | V
] (29)
and
W gzB,k =
k∏
j=1
(
αj(z)× fBj |Rj ,Lj(1 | Rj, Lj)
)Bj × (1− αj(z)× fBj |Rj ,Lj(1 | Rj, Lj))1−Bj
fBj |Rj ,Lj(Bj | Rj, Lj)
(30)
and
W gzH,k =
k∏
j=1
(
βj(z)× fHj |Sj ,Lj(1 | Sj, Lj)
)Hj × (1− βj(z)× fHj |Sj ,Lj(1 | Sj, Lj))1−Hj
fHj |Sj ,Lj(Hj | Sj, Lj)
, (31)
for k ∈ {0, . . . , K}. We provide a proof of the equivalence between the representations
in (25) and (28) in Appendix E, which only depends on the positivity assumption.
Similarly, the g-formula of expression (26) may be expressed as
f gzBj(1) =pi
gz
B,j, (32)
where
pigzB,j = E
[
BjW
gz
H,j−1W
gz
B,j−1
]
, (33)
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and the g-formula of expression (27) as
f gzHj(1) =pi
gz
H,j, (34)
where
pigzH,j = E
[
HjW
gz
B,jW
gz
H,j−1
]
. (35)
Here, λgzY,k represents the discrete time hazard for death in interval k, and pi
gz
B,k and pi
gz
H,k
are the marginal probabilities of receiving a suspected superior treatment and suspected in-
ferior treatment unit, respectively, under the regime gz, characterized by the proportionally-
representative interventions of (9) and (10) that realistically constrain treatment resources.
These alternative expressions will motivate our presentation of a particular marginal struc-
tural model (MSM) [8], introduced in Section 5.
5. Inverse Probability Weighted Estimation of Risk under Proportionally Rep-
resentative Interventions
In low-dimensional settings, large samples would allow estimation of E(Y gzK ) by non-
parametrically estimating the components of the g-formulae in expressions (25) - (27), or
equivalently the alternative formulations in (28), (32) and (34). However, in high dimen-
sional settings, e.g. when Lk takes many levels and/or when K is large, non-parametric
estimation will often be practically infeasible. One approach to overcoming this issue is to
supplement the non-parametric identification assumptions in Section 4 with restrictions on
the observed data-generating mechanism in the form of parametric modelling assumptions
such that parametric estimators can be used.
In particular, it is possible to impose parametric modelling assumptions on some or all
of the components of expression (25) (f gzYK (1)), e.g. using the parametric g-formula estimator
of Robins [1], which would likely include modelling assumptions for the K conditional treat-
ment densities that comprise the proportionally-representative intervention distributions for
regime gz, (9) and (10). These estimators are often computed via Monte Carlo simulations
using estimated model coefficients to approximate the estimator’s high-dimensional inte-
gral/sum, but are prone to bias from model-misspecification due to the large number of
conditional densities for which parametric assumptions are made.
Alternatively, we might impose modelling assumptions on λgzY,k(V ) of expression (28),
corresponding to an MSM as in Young 2018 [9], and on the components of W gzB,k and W
gz
H,k,
defined in expressions (30) and (31). Without knowledge about the structural functions
of the observed data generating mechanism, as is almost always the case, this approach
would usually be more desirable than a parametric g-formula estimator for proportionally
representative interventions, since the union of the sets of components of W gzB,K and W
gz
H,k,
respectively, defined by the 2 ×K conditional treatment densities, is a strict subset of the
set of components of the g-formula for which modelling assumptions must be made in the
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parametric g-formula. While MSMs are also subject to bias from model misspecification and
can be inefficient, the strictly smaller number of models that must be specified, and relative
computational ease of such an estimator, involving only a triplet of simple regression models
(for outcome, and the pair of treatments), provide specific advantages.
5.1. Marginal Structural Models for Proportionally Representative Interventions
A MSM parameterizes the contrast of marginal means under different regimes indexed
by z. The joint consideration of laws under different regimes requires joint consideration
of pseudo-data from generating mechanisms corresponding to these regimes. When a single
observed dataset can be partitioned into subsets following the different regimes under con-
sideration, then the joint consideration naturally follows by re-weighting each individual in
the single observed dataset according to the regime under which their observed treatment
was consistent. Alternatively, in the setting of proportionally-representative interventions,
many individuals receive treatment consistent with both regimes g0 and g1; that is, there
is a non-empty intersection between the terms in f g0YK (1) and f
g1
YK
(1) (the g-formulae for YK
under regimes g0 and g1, respectively). A general approach that allows joint consideration of
pseudo-data from worlds under both of these regimes, is to consider perfectly cloned copies
of the observed data (one for each regime under consideration), and introduce an adminis-
trative variable, Z, which indexes the particular regime that the cloned copy corresponds
to. We use this approach for the remainder of the manuscript, and therefore we re-express
λgzY,k(V ), with respect to the cloned dataset,as
λgzY,k(V ) = λY,k(Z, V ) =
E
[
Yk(1− Yk−1)WH,k(Z)WB,k(Z) | V, Z
]
E
[
(1− Yk−1)WH,k(Z)WB,k(Z) | V, Z
] , (36)
where
WB,k(Z) =
k∏
j=1
(
αj(Z)× fBj |Rj ,Lj(1 | Rj, Lj)
)Bj × (1− αj(Z)× fBj |Rj ,Lj(1 | Rj, Lj))1−Bj
fBj |Rj ,Lj(Bj | Rj, Lj)
(37)
and
WH,k(Z) =
k∏
j=1
(
βj(Z)× fHj |Sj ,Lj(1 | Sj, Lj)
)Hj × (1− βj(Z)× fHj |Sj ,Lj(1 | Sj, Lj))1−Hj
fHj |Sj ,Lj(Hj | Sj, Lj)
.
(38)
Similarly, we reexpress pigzB,j and pi
gz
H,j, respectively, as
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piB,j(Z) = E
[
BjWH,j−1(Z)WB,j−1(Z)
]
(39)
and
piH,j(Z) = E
[
HjWB,j(Z)WH,j−1(Z)
]
. (40)
Now, assume that there exists a real-valued parameter ψ∗, such that, for a user-specified
V , the following holds for all values of k, Z, and V ,
h{γ(k, Z, V ;ψ)} = E
[
Yk(1− Yk−1)WH,k(Z)WB,k(Z) | V, Z
]
E
[
(1− Yk−1)WH,k(Z)WB,k(Z) | V, Z
] , (41)
where ψ = ψ∗; h{·} is a known link function constrained between 0 and 1 (e.g. the logit or
probit functions); and γ(·) is defined to be some function of k, Z, and V that is differentiable
with respect to ψ and is not a function of Z when ψ = 0 (so that the sharp null hypothesis
of no effect of regime g1 versus g0 on survival at any time k, Yk, along with exchangeability
conditions (17)-(20), implies ψ∗ = 0). Then, (41) is an MSM for the discrete-time hazard of
death at k, conditional on V, and under regimes indexed by Z, defined by the proportionally-
representative interventions of (9) and (10) that realistically constrain treatment resources.
Given the MSM in (41) holds, (28) may be re-written as
∑
v
K∑
k=1
h{γ(k, z, v;ψ)}
k−1∏
j=1
[1− h{γ(k, z, v;ψ)}]f(v), (42)
,
when ψ = ψ∗.
5.2. Inverse Probability Weighted Estimation
Let ψˆ be the solution to the estimating equation
n∑
i=1
∑
z
K∑
k=1
Ui,k(ψ, ηˆB, ηˆH) = 0, (43)
,
with respect to ψ, where
Uk(ψ, ηˆB, ηˆH) =[Yk − h{γ(k, Z, V ;ψ)}] (44)
× (1− Yk−1)WB,k(Z, ηˆB)WH,k(Z, ηˆH).
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Here, let
WB,k(Z, ηˆ) =
k∏
j=1
(
αj(Z, ηˆ)× fBj |Rj ,Lj(1 | Rj, Lj; ηˆB)
)Bj × (1− αj(Z, ηˆ)× fBj |Rj ,Lj(1 | Rj, Lj; ηˆB))1−Bj
fBj |Rj ,Lj(Bj | Rj, Lj; ηˆB)
,
(45)
and
WH,k(Z, ηˆ) =
k∏
j=1
(
βj(Z, ηˆ)× fHj |Sj ,Lj(1 | Sj, Lj; ηˆH)
)Hj × (1− βj(Z, ηˆ)× fHj |Sj ,Lj(1 | Sj, Lj; ηˆH))1−Hj
fHj |Sj ,Lj(Hj | Sj, Lj; ηˆH)
,
(46)
where η ≡ {ηB, ηH}, fBj |Rj ,Lj(Bj | Rj, Lj; ηB) and fHj |Sj ,Lj(Hj | Sj, Lj; ηH) are models for
the denominators of (45) and (46), and ηˆB and ηˆH are the MLEs of ηB and ηH , respectively.
Here, α1(z, ηˆ) is estimated by
P (BgZ+1 = 1)
1
n
∑n
i=1Bi,1
, (47)
and αj(Z, ηˆ) and βj−1(Z, ηˆ) are obtained recursively for j = 2, . . . , K + 1, respectively,
from
αj(Z, ηˆ) =
P (BgZ+j = 1)
pˆiB,j(Z, ηˆ)
(48)
and
βj(Z, ηˆ) =
P (HgZ+j = 1)
pˆiB,j(Z, ηˆ)
(49)
where
pˆiB,j(Z, ηˆ) =
1
n
n∑
i=1
[
Bi,jWH,i,j−1(Zi, ηˆ)WB,i,j−1(Zi, ηˆ)
]
(50)
and
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pˆiH,j(Z, ηˆ) =
1
n
n∑
i=1
[
Hi,jWB,i,j(Zi, ηˆ)WH,i,j−1(Zi, ηˆ)
]
. (51)
Here, P (BgZ+j = 1) and P (H
gZ+
j = 1) are defined by the user-specified proportionally-
representative interventions, piB,j(Z, η) and piH,j(Z, η) are models for piB,j(Z) and piH,j(Z),
and pˆiB,j(Z, ηˆ) and pˆiH,j(Z, ηˆ) are their MLEs.
Following Robins (1999) [10], if (i) the MSM of (41) is correctly specified; and (ii), the
models fBj |Rj ,Lj(Bj | Rj, Lj; ηB) and fHj |Sj ,Lj(Hj | Sj, Lj; ηH) of the denominators for (45)
and (46) are correctly specified, then we have
E[Uk(ψ∗, η∗B, η∗H)] = 0 (52)
for all k, with η∗B and η
∗
H the true values of ηB and ηH and the IPW estimator ψˆ consistent
and asymptotically normal for ψ∗.
Here, we assume pooled logistic models for h{γ(k, Z, V ;ψ)}, fBk|Rk,Lj(Bk | 1, Lk; ηB) and
fHk|Sk,Lj(Hk | 1, Lk; ηH), that is,
h{γ(k, Z, V ;ψ)} = expit{γ(k, Z, V ;ψ)} (53)
and
fBk|Rk,Lk(1 | 1, Lk; ηB) = expit{φB(k, Lk; ηB)} (54)
and
fHk|Sk,Lk(1 | 1, Lk; ηH) = expit{φH(k, Lk; ηH)} (55)
with φB and φH specified functions of (k, Lk), differentiable with respect to ηB and
ηH , respectively, and expit(·) = exp(·)1+exp(·) . Note that fBk|Rk,Lj(0 | 0, Lk; ηB) = fHk|Sk,Lj(0 |
0, Lk; ηB) = 1 by definition (that is, previously treated or deceased individuals will be
untreated in interval k, with probability 1).
A solution to (43) is obtained through the following algorithm applied to a cloned subject-
interval dataset with administrative variable Z, constructed such that each subject will have
K∗ lines indexed by k = 1, . . . , K∗, where K∗ = K if YK = 0, else K∗ = min({j | Yj = 1}),
so that K∗ = K when a subject is alive at the end of follow-up or equals the interval number
during which a subject dies during follow-up.
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5.2.1. IPW estimation algorithm for ψ
1. Using subject-interval records with Z = 1 and Rk = 1, obtain ηˆB by fitting pooled
logistic regression model (54) with dependent variable Bk and independent variables
a specified function of k = 0, . . . , K and Lk, corresponding to the choice of φB(·).
2. Similarly, using subject-interval records with Z = 1 and Sk = 1, obtain ηˆH by fitting
a pooled logistic regression model (55) with dependent variable Hk and independent
variables a specified function of k = 0, . . . , K and Lk, corresponding to the choice of
φH(·).
3. Set α0(z, ηˆ) and β0(z, ηˆ) to 1. Using subject-interval records with Z = 1, obtain
α1(1, ηˆ) by evaluating the ratio in (47): dividing P (B
g1+
1 = 1) (defined by the inter-
vention), by the proportion of individuals with B1 = 1,
1
n
∑n
i=1Bi,1. Likewise, using
subject-interval records with Z = 0, obtain α1(0, ηˆ).
4. For each subject’s line 1, attach the suspected-superior treatment weight, WB,1, cal-
culated as
(
α1(Z, ηˆ)× expit{φB(1, L1; ηˆB)}}
)B1 × (1− α1(Z, ηˆ)× expit{φB(1, L1; ηˆB)})1−B1(
expit{φB(1, L1; ηˆB)}
)B1 × (1− expit{φB(1, L1; ηˆB)})1−B1
5. Using subject-interval records with Z = 1, obtain β1(1, ηˆ) by evaluating the ratio in
(49): dividing P (Hg1+1 = 1) (defined by the intervention), by the weighted proportion
of individuals with H1 = 1,
1
n
∑n
i=1Hi,1WB,i,1. Likewise, obtain β1(0, ηˆ).
6. For each subject’s line 1, attach the suspected-inferior treatment weight, WH,1, calcu-
lated as
[(
β1(Z, ηˆ)× expit{φH(1, L1; ηˆH)}
)H1 × (1− α1(Z, ηˆ)× expit{φH(1, L1; ηˆH)})1−H1(
expit{φH(1, L1; ηˆH)}
)H1 × (1− expit{φH(1, L1; ηˆH)})1−H1
]S1
7. For z ∈ {0, 1}, iterate from k = 2, . . . K:
7.1. Using subject-interval records on line k with Z = z, obtain αk(z, ηˆ) by evaluating
the ratio in (48), dividing P (Bgz+k = 1) (defined by the intervention) by the
weighted proportion of individuals with Bk = 1,
1
n
∑n
i=1
[
Bi,kWB,i,k−1WH,i,k−1
]
.
7.2. Using subject-interval records on line k with Z = z, attach the suspected-superior
treatment weight, WB,k, calculated as
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k∏
j=1
[(
αj(z, ηˆ)× expit{φB(j, Lj; ηˆB)}
)Bj × (1− αj(z, ηˆ)× expit{φB(j, Lj; ηˆB)})1−Bj(
expit{φB(j, Lj; ηˆB)}
)Bj × (1− expit{φB(j, Lj; ηˆB)})1−Bj
]Rj
7.3. Using subject-interval records on line k with Z = z, obtain βk(z, ηˆ) by evaluat-
ing the ratio in (49), dividing P (Hgz+k = 1) (defined by the intervention) by the
weighted proportion proportion of individuals withHk = 1,
1
n
∑n
i=1
[
Hi,kWB,i,kWH,i,k−1
]
.
7.4. Using subject-interval records on line k with Z = z, attach the suspected-superior
treatment weight, WH,k, calculated as:
k∏
j=1
[(
βj(z, ηˆ)× expit{φH(j, Lj; ηˆH)}
)Hj × (1− αj(z, ηˆ)× expit{φH(j, Lj; ηˆH)})1−Hj(
expit{φH(j, Lj; ηˆH)}
)Hj × (1− expit{φH(j, Lj; ηˆH)})1−Hj
]Sj
8. Using all subject-interval records in the cloned dataset, obtain ψˆ by fitting a weighted
pooled logistic regression model, with weights WB,k and WH,k defined in the previous
steps, dependent variable Yk and independent variables a specified function of k =
1, . . . , K and (Z, V ) corresponding to the choice of γ(·).
Our final IPW estimate of the g-formula for the risk of death byK under regime gz, f
gz
YK
(1)
defined by the proportionally-representative interventions of (9) and (10) that constrain
resources can then be obtained by the plug-in estimator
n∑
i=1
K∑
k=1
expit{γ(k, z, Vi; ψˆ)}
k−1∏
j=1
[1− expit{γ(k, z, Vi; ψˆ)}]. (56)
We provide extensions of the above algorithm to settings with arbitrary resource con-
straints and loss-to-follow-up in Appendix F.
6. Data Analysis
Patients in need of a liver transplant can only receive a transplant if a suitable organ
is available. The treatment (receive a transplant) is clearly a limited resource and the con-
straint imposed by organ availability should be satisfied in a policy-relevant study. Although
the proportion of organ donors in the U.S. has risen considerably over the past two decades
[11], many of these organs are classified as ‘increased risk’ organs because their utilization
might result in a higher probability of unintended transmission of HIV, hepatitis B, and/or
hepatitis C to recipients [12]. Therefore, policy makers might be interested in learning how
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a restrictive policy of using only ‘standard risk’ organs (a suspected superior treatment re-
source) would impact survival of wait-listed patients compared with the current practice
of using both ‘standard risk’ and ‘increased risk’ organs (a suspected inferior treatment
resource). Given the limited number of total livers available for transplantation, implemen-
tation of any restrictive policy will necessarily increase the length of time that candidates
wait for a transplant. So, in other words, a first question of interest is whether increasing the
time candidates are waiting for a standard-risk organ, and therefore the number of candi-
dates who die while on the waiting list, is outweighed by a suspected longer survival among
those who ultimately receive such a transplant. If this is false, policy makers might want
to consider increasing utilization of increased risk organs. Already, some clinicians hesitate
to use ‘increased risk’ organs [13, 14, 15], so it is possible that the system could increase
the utilization of these organs by simply discarding less organs. Policy makers might be
interested in learning how a policy that increases the utilization of ‘increased risk’ organs
(a suspected inferior treatment resource) would impact survival of wait-listed patients com-
pared with the current practice. So, in other words, a second question of interest is whether
decreasing the time candidates wait for a standard-risk organ is outweighed by a suspected
shorter survival among those who ultimately receive ‘increased risk’ organ transplants.
Motivated by this policy relevant question, we used data from the Scientific Registry of
Transplant Recipients (SRTR) to study the causal effect of different transplantation policies.
The SRTR data system is a repository of information for all candidates ever added to the
United States Organ Procurement and Transplantation Network (OPTN) waiting list. The
data were restricted to those from individuals aged 18 or older with no prior history of liver
transplantation, who were eligible for liver transplantation and were added to the OPTN
waiting list to receive a liver organ between 2005 to 2015, and were followed until death, loss
to follow-up (as reported by individual transplant programs), or May 31st, 2016, whichever
occurs first. The SRTR includes data on wait-list candidate mortality via linkage to the
National Death Index [16]. Over the study period, n=93,812 transplant candidates were
added to the waitlist, of whom 51,322 received livers from deceased donors. Data were
coarsened into discrete 30-day intervals, where k=1 corresponds to an individual’s first 30-
day interval upon entering the waitlist. Data are used to estimate the 10-year (YK where
K = 120) cumulative incidence of death under the following regimes:
g0. Current practice: “standard risk” and “increased risk” organs are utilized at current
levels,
g1. Restrictive practice: “standard risk” organs are utilized at current levels and “increased
risk” organ utilization is abolished,
g2. Expansive practice A: “standard risk” organs are utilized at current levels and “in-
creased risk” organ utilization is increased by 25%,
g3. Expansive practice B: “standard risk” organs are utilized at current levels and “in-
creased risk” organ utilization is increased by 50%,
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where each of these regimes targets outcomes under the “natural course”, that is, under
hypothetical interventions that abolish censoring, and for simplicity, under interventions
that abolish utilization of transplants other than “standard risk” or “increased risk” organs
(organs from living donors,cardiac-death donors, donors who are not HIV, hepatitis C, and
hepatitis B seronegative, or donors with unknown risk status). We used the IPW estimation
algorithm described in Section 5.2.1, adapted for censoring weights and weights for “other”
transplant types, as in Appendix F.
We defined Bk to indicate reception of a “standard risk” organ, and Hk to indicate
reception of an “increased risk” organ, in interval k. We defined V to be the empty set,
∅. For k = 2, . . . , K, interval k confounders Lk included waiting-list priority in the form
of model for end-stage liver disease [MELD] score, MELD score exception, and urgent-need
status. Interval 1 confounders L1 additionally included year of listing to the waiting list,
gender, race, age, height, weight, willingness to accept a less optimal organ (i.e. a liver
segment, a organ from an incompatible blood type donor, or a donor with hepatitis B or C),
need for life support, functional status, primary diagnosis leading to liver failure, history
of complications or procedures related to liver failure (i.e. spontaneous bacterial peritonitis,
portal vein thrombosis, transjugular intrahepatic portosystemic shunt).
Regimes are comprised of proportionally representative interventions that assign treat-
ment according to the general expressions in Appendix A (for which expressions in (9) and
(10) are a special case), and limit treatment resource utilization according to the following
constraints, for k = 1, . . . K:
g0. Current practice: P (B
g0+
k = 1) = P (Bk = 1) and P (H
g0+
k = 1) = P (Hk = 1),
g1. Restrictive practice: P (B
g1+
k = 1) = P (Bk = 1) and P (H
g1+
k = 1) = 0,
g2. Expansive practice A: P (B
g2+
k = 1) = P (Bk = 1) and P (H
g0+
k = 1) = min
(
1.25 ×
P (Hk = 1), P (S
g2
k = 1)
)
,
g3. Expansive practice B: P (B
g3+
k = 1) = P (Bk = 1) and P (H
g3+
k = 1) = min
(
1.5 ×
P (Hk = 1), P (S
g3
k = 1)
)
.
All regimes, gz included hypothetical interventions to abolish censoring - that is, we
targeted potential outcomes under proportionally representative interventions that would
occur during the natural course where no individual was censored. We discuss extensions to
censoring and resulting procedures in appendices D and F.
6.1. Marginal Structural Models
We assumed the following functional form for γ of the MSM in (41). Specifically,
γ(k, Z, V ;ψ) = ψ0 + ψ
T
1 g(k) + ψ2Z + ψ3Zk, (57)
and we specify the weight models in Appendix G.
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6.2. Results
The utilization of ‘standard risk’ and ‘increased risk’ organs under the hypothetical
treatment regimes over a follow-up period of 10 years are shown in figures 4 and 5. The
utilization of ‘standard risk’ organs is identical in the weighted data under all treatment
strategies, which visually confirms that the treatment resource constraints are satisfied.
The estimated 10-year cumulative incidence of death is 59.3% (95% confidence interval
[CI]: 58.8 to 59.9%) under regime g0, corresponding to the current practice of using both
‘standard risk’ and ‘increased risk’ organs, in contrast to 64.9% (95% CI: 62.7 to 67.9%)
under regime g1, corresponding to the restrictive practice of using only ‘standard risk’ organs.
That is, an estimated difference of 5.6 percentage points (95% CI: 3.4 to 8.6 percentage
points). The cumulative incidence curves for death under regimes g0 and g1 are displayed
in figure 2.
The estimated 10-year cumulative incidence of death is 58.4% (95% CI: 57.8 to 58.9%)
under regime g2, corresponding to the expansive practice of the increasing utilization of
‘increased risk’ organs by a factor of 1.25, an incidence 1.0 percentage points lower than what
would be observed under regime g0 (95% CI: -1.4, -0.7 percentage points), and the estimated
cumulative incidence is 57.4% (95% CI: 56.6 to 58.1%) under regime g3, corresponding to
the expansive practice of the increasing utilization of ‘increased risk’ organs by a factor of
1.5. That is, an incidence 1.9 percentage points lower than what would be observed under
regime g0 (95% CI: – to –% percentage points). The cumulative incidence for death under
regimes g0, g2, and g3 are displayed in figure 3.
In other words, we estimated that, despite the concerns regarding infectious disease
transmission and organ inferiority, a policy of abolishing utilization of ‘increased risk’ organs
would have increased the cumulative incidence of death by 5.6 percentage points at 10 years
after addition to the waiting list, and that increasing utilization of ‘increased risk’ organs
would actually increase overall survival, compared to current practice.
All analyses were performed using R version 3.5.2 and code is available to reproduce
these results, as well as to flexibly estimate the effects of other proportionally-representative
interventions on ‘standard risk’ and ‘increased risk’ organ utilization. Ninety-five percent
confidence intervals were obtained from the 97.5th and 2.5th percentiles of the distribution of
point estimates obtained by repeating the IPW algorithm on 500 nonparametric bootstrap
samples.
7. Conclusion
In this article we have presented a novel class of policy-relevant estimands: expected po-
tential outcomes under proportionally-representative interventions that constrain treatment
resources. These estimands are policy-relevant because they (i) incorporate substantive
knowledge to specify limits on treatment utilization that are feasibly achieved under an
actual policy and (ii) coarsely preserve features of the observed joint distribution between
treatment and covariates - specifically, the rank-order of conditional treatment probabilities,
which would naturally be unperturbed in settings where the intervention is a manipulation
of treatment resource scarcity.
21
Our estimands stand in contrast to the classical population-level estimand - equal to
the average treatment effect of deterministic regimes - which we show is a special case of
proportionally-representative interventions where treatment resources are assumed (often
absurdly) to be practically unlimited. To facilitate the concerns of policy-makers, we pro-
vide simple inverse probability-weighted estimators for proportionally-representative inter-
ventions, implementable with off the shelf-software. These estimators are consistent under
mildly stronger identification assumptions than those typically needed for most causal esti-
mands.
We demonstrated the use of the proportionally representative interventions in a study
of organ transplantation policies, where treatment resource limitations are severe. Evidence
from our marginal structural models supports the continued (and possible expanded) use
of the suspected inferior treatment resource (the so-called “increased-risk” liver grafts),
suggesting that the increased scarcity imposed by elimination of these grafts outweighs the
suspected inferiority of receiving these grafts, with respect to the cumulative incidence of
death in the population of transplant eligible individuals.
Our class of estimands generalizes previously used unlimited resource estimands and
are easy to implement. However, the representative nature of the stochastic interventions
may not always correspond to a policy that is of substantive interest. Specifically, policy
makers might be interested in effects of alternative prioritization mechanisms, for exam-
ple, hypothetical policies corresponding to alternative algorithms for rank determination on
the national waiting list for liver transplants. Such estimands fall outside of the class de-
fined by proportionally-representative interventions because the representative nature of the
stochastic interventions is tantamount to preserving the natural (observed) prioritization
of individuals with different covariate values under the regimes considered. We will study
extensions of our results to a broader class of realistic, policy-relevant estimands in future
work.
22
L1
gz
U1
gz
B1
gz | b1 H1gz | h1 Y1gz L2gz B2gz | b2 H2gz | h2 Y2gz
Figure 1: SWIT (K=2)in which Exchangeability 1 and 2 hold.
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Figure 2: Potential outcomes under regimes g0 and g1
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Figure 3: Potential outcomes under regimes g0, g2, and g3
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Figure 4: Organ utilization under regimes g0 and g1
Figure 5: Organ utilization under regimes g0, g2, and g3
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8. Appendix A: Extension to arbitrary resource constraints
In the main text, we present regimes and corresponding identification and estimation
results for a subset of possible proportionally representative interventions, where treatment
resources are either eliminated or are constrained to utilization equal to that under the
observed data generating mechanism. In this Appendix, we generalize results for the full
class of proportionally representative interventions, where resource utilization is constrained
to any arbitrary level.
8.1. Regimes
As before, regimes are determined by the user-defined treatment resource constraints
qgzk and m
gz
k . However, they must be adapted to respect the additional constraint imposed
by the finite treatment population - a regime could not possibly use more treatment units
than there are treatment-eligible individuals under that regime in a given interval. As such,
constraints are re-expressed as:
Qgzk = min
(
qgzk ,
P (Rgz+k = 1)
P (Bk = 1)
)
, (58)
and
M gzk = min
(
mgzk ,
P (Sgz+k = 1)
P (Hk = 1)
)
(59)
for all k ∈ {1, . . . , K}.
In words, we have adapted the constraints so that the resources are utilized to the highest
possible extent that does not exceed the user-specified resource limitation: either that limit,
or the number of treatment eligible individuals if that limit exceeds the latter.
For notational convenience, we re-express the constraints in terms of probabilities and in
terms of variables ℵgzB,k and ℵgzH,k, that indicate whether the user-specified resource limitations
exceed the expected number of treatment eligible individuals under regime gz within a
particular interval:
P (Bgz+k = 1) =
(
qgzk × P (Bk = 1)
)ℵgzB,k
(60)
×
(
P (Rgz+k = 1)
)1−ℵgzB,k
(61)
and:
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P (Hgz+k = 1) =
(
mgzk × P (Hk = 1)
)ℵgzH,k
(62)
×
(
P (Sgz+k = 1)
)1−ℵgzH,k
(63)
In particular, ℵgzH,k and ℵgzB,k are precisely defined as
ℵgzB,k = I
(
qgzk × P (Bk = 1) ≤ P (Rgz+k = 1)
)
(64)
and
ℵgzB,k = I
(
mgzk × P (Hk = 1) ≤ P (Sgz+k = 1)
)
(65)
In words, the marginal probability of post-intervention suspected-inferior treatment uti-
lization under regime gz, P (B
gZ+
k = 1), is specified to be equal to q
gz
k × P (Bk = 1), or the
marginal probability of suspected-inferior treatment eligibility under regime gz, P (R
gZ+
k =
1), if the latter exceeds the former. These were not needed in the main text, since ℵgzB,k and
ℵgzH,k are guaranteed to evaluate to 1 for all k ∈ {1, . . . , K} under regimes g1 and g0 specified
in expressions (5) - (8), as we proove in Lemma (1) at the end of Appendix A.
Now, as in expressions (5) - (8) for particular regimes g1 and g0, we have fully specified
the marginal resource constraints to be realized under an arbitrary regime gz. However, since
all of the conditions of Lemma (1) are not met under an arbitrary regime gz, specifically
that P (Bgz+k = 1) and P (H
gz+
k = 1) are not less than or equal to P (Bk = 1) and P (Hk = 1),
respectively, for all k ∈ {1, . . . , K}, then αk(z) and βk(z) as defined in expressions (11) and
(12) in the main text may not be less than or equal to 1 for all k ∈ {1, . . . , K}. By conse-
quence, there is no guarantee that the conditional intervention density function as defined
in expressions (9) and (10) in the main text will always evaluate to some number between
0 and 1 and thus may not be a valid probability density function. As such, we redefine the
conditional intervention distributions of the proportionally representative interventions to
preclude this possibility.
First, we define additional variables igzB,k and i
gz
H,k, which indicate when the pre-specified
post-intervention marginal treatment probability exceeds the natural marginal treatment
probability, under regime gz for both the suspected inferior and superior treatments:
igzB,k = I
(
P (Bgzk = 1) > P (B
gz+
k = 1)
)
(66)
and
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igzH,k = I
(
P (Hgk = 1) > P (H
gz+
k = 1)
)
(67)
We remind the reader that, under a particular regime, the natural treatment values are
the values we would observe at the moment before treatment intervention. Therefore, for
example, P (Bgz2 = 1) is the probability of receiving a suspected superior treatment unit
under regime gz, where we have intervened on suspected superior and suspected inferior
treatment in interval 1, but we have not yet intervened on suspected superior treatment in
interval 2.
Thus we the define the arbitrary regime gz to be a stochastic intervention on Hk and Bk
for all k ∈ {1, ..., K}, such that intervention distributions are defined as follows:
fBgz+k |Rgz+k ,L
gz
k
(1 | Rk, Lk) =
(
αk(z,Rk)× fBk|Rk,Lk(1 | Rk, Lk)
)igzB,k (68)
×(1− αk(z, Rk)× fBk|Rk,Lk(0 | Rk, Lk))1−igzB,k ,
and
fHgz+k |Sgz+k ,L
gz
k
(1 | Sk, Lk) =
(
βk(z, Sk)× fHk|Sk,Lk(1 | Sk, Lk)
)igzH,k (69)
×(1− βk(z, Sk)× fHk|Sk,Lk(0 | Sk, Lk))1−igzH,k ,
with probability 1, where fBk|Rk,Lk(· | ·) and fBgz+k |Rgz+k ,Lgzk (· | ·) are defined as in the main
text. Additionally, αk(z) and βk(z) are regime-specific specific variables defined to satisfy
resource constraints, adapted for the arbitrary regime gz as follows:
αk(z,Rk) =
[(
P (Bgz+k = 1)
P (Bgzk = 1)
)igzB,k
(70)
×
(
1− P (B
gz+
k =1)
P (Rgz+k =1)
1− P (B
gz
k =1)
P (Rgz+k =1)
)(1−igzB,k)
×
(
ℵgzB,k
)]Rk
,
and
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βk(z, Sk) =
[(
P (Hgz+k = 1)
P (Hgzk = 1)
)igzH,k
(71)
×
(
1− P (H
gz+
k =1)
P (Sgz+k =1)
1− P (H
gz
k =1)
P (Sgz+k =1)
)(1−igzH,k)
×
(
ℵgzH,k
)]Sk
,
for all k ∈ {1, . . . , K}.
Here, we see that αk(z,Rk) and βk(z, Sk) are random variables only with respect to Rk
and Sk, respectively. Thus, αk(z,Rk) is a scaling function that:
1. Evaluates to 1 whenever Rk = 0 (that is, it does not scale one’s probability of receiving
or not receiving the suspected-superior treatment if one is not eligible to receive the
suspected-superior treatment), else:
2. Evaluates to 0 whenever ℵgzB,k = 0 (in which case, igzH,k = 0), and so the conditional
probabilities of not receiving an organ are set to 0, else:
3. Evaluates to some number between 1 and 0, and are applied to the conditional prob-
abilities of receiving or not receiving the suspected-superior treatment, depending on
the value of igzB,k. We leave proof of this particular claim to the reader, as it follows
naturally from definitions of the indicator variables.
In the context of the expression of the weights above, igzB,k indicates whether or not
constraint satisfaction demands an intervention that scales up or scales down the natural
likelihood of suspected-superior treatment reception, whereas ℵgzB,k indicates whether or not
constraint satisfaction demands an intervention that assigns the suspected-superior treat-
ment to all eligible individuals.
To provide additional intuition about the expressions for αk(z,Rk) we note that P (B
gz+
k =
1) = P (Bgz+k = 1, R
gz+
k = 1), due to the determinism between B
gz+
k and R
gz+
k . And so:
P (Bgz+k = 1)
P (Bgzk = 1)
=
P (Bgz+k = 1 | Rgz+k = 1)
P (Bgzk = 1 | Rgz+k = 1)
and:
1− P (B
gz+
k =1)
P (Rgz+k =1)
1− P (B
gz
k =1)
P (Rgz+k =1)
=
P (Bgz+k = 0 | Rgz+k = 1)
P (Bgzk = 0 | Rgz+k = 1)
Therefore, when ℵgzB,k = 1 then αk(z, Rk) evaluates to a ratio of the conditional proba-
bilities of post-intervention and natural treatment reception under regime gz.
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8.2. Identification
In addition to identification conditions (17) - (24), we require the following exchange-
ability conditions for Hgzk , analogous to Exchangeability 2 conditions (19) and (20):
Hgzt ⊥ I(Bgzt = bt) | Lgzt = lt, Y gzt−1 = 0, Hgzt−1 = ht−1, Bgzt−1 = bt−1, (72)
for {bt, lt, ht−1 | P (Bgz+t−1 = bt, Lgzt = lt, Y gzt−1 = 0, Hgz+t−1 = ht−1) > 0}, t ∈ {1, . . . , k},
and:
Hgzt ⊥ I(Hgzt−1 = ht−1) | Bgzt−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = 0, Hgzt−2 = ht−2, (73)
for {ht−1, Bgzt−1 = bt−1, lt−1 | P (Hgz+t−1 = ht−1Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = 0) > 0},
t ∈ {1, . . . , k}.
These additional exchangeability conditions are required to identify βk(z, Sk), which
cannot be trivially identified as evaluating to either 0 or 1, as in regimes g1 and g0 described
in the main text.
8.2.1. Identification formulae
As in Section 4.5, when all identification conditions hold, including (72) and (73), we can
identify E(Y gzK ) from the same non-extended g-formula of Robins (1986) for YK , f
gz
YK
(1): equal
to (25), except now αk(z,Rk) and βk(z, Sk) are identified by the functionals in expressions
(70) and (71), and ℵ and i indicator functions are identified by the functionals in expressions
(64) - (67), except replacing P (Bgzk = 1) with f
gz
Bk
(1) of (26), P (Hgzk = 1) with f
gz
Hk
(1) of
(27), and P (Rgz+k = 1) with f
gz
Rk
(1) and P (Sgz+k = 1) with f
gz
Sk
(1), where f gzRk(1) and f
gz
Sk
(1)
are the g-formulae for Rk and Sk, respectively:
f gzRk(1) =
∑
lk−1
P (Yk−1 = 0 | Hk−1 = 0, Bk−1 = 0, Lk−1 = lk−1, Yk−2 = 0) (74)
×
k−1∏
m=1
{
fHgz+m |Sgz+m ,Lgzm (0 | 1, lm)
× fBgz+m |Rgz+m ,Lgzm (0 | 1, lm)
× P (Lm = lm | Rm = 1, Lm−1 = lm−1)
× P (Ym−1 = 0 | Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
}
,
and
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f gzSk(1) =
∑
lk
fBgz+k |Rgz+k ,Lk(1 | 1, lk) (75)
× P (Lk = lk | Rk = 1, Lk−1 = lk−1) (76)
×
k−1∏
m=1
{
P (Ym = 0 | Hm = 0, Sm = 1, Lm = lm)
× fHgz+m |Sgz+m ,Lgzm (0 | 1, lm)
× fBgz+m |Rgz+m ,Lm(0 | 1, lm)
× P (Lm = lm | Rm = 1, Lm−1 = lm−1)
}
.
8.2.2. Alternative g-formulae representation
As in the main text, the g-formula can be represented as in expressions (28) and (29),
but where W gzB,k and W
gz
H,k are expressed as follows:
W gzB,k =
k∏
j=1

((
αj(z,Rj)×fBj |Rj,Lj (1|Rj ,Lj)
)Bj
×
(
1−αj(z,Rj)×fBj |Rj,Lj (1|Rj ,Lj)
)1−Bj
fBj |Rj,Lj (Bj |Rj ,Lj)
)igzB,k
×
((
1−αj(z,Rj)×fBj |Rj,Lj (0|Rj ,Lj)
)Bj
×
(
αj(z,Rj)×fBj |Rj,Lj (0|Sj ,Lj)
)1−Bj
fBj |Rj,Lj (Bj |Rj ,Lj)
)(1−igzB,k)
 .
(77)
and
W gzH,k =
k∏
j=1

((
βj(z,Sj)×fHj |Sj,Lj (1|Sj ,Lj)
)Hj
×
(
1−βj(z,Sj)×fHj |Sj,Lj (1|Sj ,Lj)
)1−Hj
fHj |Sj,Lj (Hj |Sj ,Lj)
)igzH,k
×
((
1−βj(z,Sj)×fHj |Sj,Lj (0|Sj ,Lj)
)Hj
×
(
βj(z,Sj)×fHj |Sj,Lj (0|Sj ,Lj)
)1−Hj
fHj |Sj,Lj (Hj |Sj ,Lj)
)(1−igzH,k)
 .
(78)
The g-formulae for Bk and Hk are expressed as in (32) and (32), and the additional
g-formulae for Rk and Sk are expressed as:
f gzRj(1) =pi
gz
R,j, (79)
where
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pigzR,j = E
[
RjW
gz
H,j−1W
gz
B,j−1
]
(80)
and the g-formula of expression (27) as:
f gzSj (1) =pi
gz
S,j, (81)
where
pigzS,j = E
[
SjW
gz
B,jW
gz
H,j−1
]
. (82)
8.3. Inverse Probability Weighted Estimation of Risk under Proportionally Representative
Interventions
8.3.1. Marginal Structural Models
Consider a cloned dataset as in subsection 5.1 of the main text, except there are as many
cloned copies as their are regimes under consideration, where Z is the support of Z, and
whose instantiations z index a particular regime gz. Then λ
gz
Y,k(V ), is likewise re-expressed
as in (36) where
WB,k(Z) =
k∏
j=1

((
αj(Z,Rj)×fBj |Rj,Lj (1|Rj ,Lj)
)Bj
×
(
1−αj(Z,Rj)×fBj |Rj,Lj (1|Rj ,Lj)
)1−Bj
fBj |Rj,Lj (Bj |Rj ,Lj)
)iB,k(Z)
×
((
1−αj(Z,Rj)×fBj |Rj,Lj (0|Rj ,Lj)
)Bj
×
(
αj(Z,Rj)×fBj |Rj,Lj (0|Rj ,Lj)
)1−Bj
fBj |Rj,Lj (Bj |Rj ,Lj)
)(1−iB,k(Z))
 .
(83)
and
WH,k(Z) =
k∏
j=1

((
βj(Z,Sj)×fHj |Sj,Lj (1|Sj ,Lj)
)Hj
×
(
1−βj(Z,Sj)×fHj |Sj,Lj (1|Sj ,Lj)
)1−Hj
fHj |Sj,Lj (Hj |Sj ,Lj)
)iH,k(Z)
×
((
1−βj(Z,Sj)×fHj |Sj,Lj (0|Sj ,Lj)
)Hj
×
(
βj(Z,Sj)×fHj |Rj,Lj (0|Sj ,Lj)
)1−Hj
fHj |Sj,Lj (Hj |Sj ,Lj)
)(1−iH,k(Z))
 .
(84)
Then, piB,j(Z) and piH,j(Z) are defined as in (39) and (40) and piR,j(Z) and piS,j(Z) are
defined analogously. ℵ and i indicator functions for the MSM are defined as in (64) -
(67), except replacing f gzWj(1) g-formulae expressions with piW,j(Z) expressions, for arbitrary
variable Wj.
Finally, the MSM is written as in (41) and, given the MSM holds, the g-formula for YK
is again re-written as in (42).
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8.3.2. Inverse Probability Weighted Estimation
Estimating equations are the same as in expressions (43) and (44), where estimated
weights WB,k(Z, ηˆB) and WH,k(Z, ηˆH) and their components are analogously defined for
the arbitrary intervention, again swapping fBj |Rj ,Lj(Bj | Rj, Lj; ηˆB) for fBj |Rj ,Lj(Bj | Rj, Lj)
and fHj |Sj ,Lj(Hj | Rj, Lj; ηˆH) for fHj |Sj ,Lj(Hj | Rj, Lj) in all places. Estimators for pˆiB,j(Z, ηˆ)
and pˆiH,j(Z, ηˆ) are defined as in Section 5.2, and estimators for pˆiR,j(Z, ηˆ) and pˆiS,j(Z, ηˆ) are
defined analagously as follows:
pˆiR,j(Z, ηˆ) =
1
n
n∑
i=1
[
Ri,jWH,i,j−1(Zi, ηˆ)WB,i,j−1(Zi, ηˆ)
]
(85)
and
pˆiS,j(Z, ηˆ) =
1
n
n∑
i=1
[
Si,jWB,i,j(Zi, ηˆ)WH,i,j−1(Zi, ηˆ)
]
. (86)
.
Then, as before, if (i) the MSM is correctly specified; and (ii), the models fBj |Rj ,Lj(Bj |
Rj, Lj; ηB) and fHj |Sj ,Lj(Hj | Sj, Lj; ηH) are correctly specified, then
E[Uk(ψ∗, η∗B, η∗H)] = 0 (87)
for all k, with η∗B and η
∗
H the true values of ηB and ηH and the IPW estimator ψˆ con-
sistent and asymptotically normal for ψ∗. Assuming the same models for h{γ(k, Z, V ;ψ)},
fBk|Rk,Lj(Bk | 1, Lk; ηB) and fHk|Sk,Lj(Hk | 1, Lk; ηH) as in expressions (53) - (55), we can
solve the estimating equation with the following generalized algorithm, applied to a cloned
subject-interval dataset, constructed as before:
Generalized IPW estimation algorithm for ψ
1. Using subject-interval records with Z = 1 and Rk = 1, obtain ηˆB by fitting pooled
logistic regression model (54) with dependent variable Bk and independent variables
a specified function of k = 0, . . . , K and Lk, corresponding to the choice of φB(·).
2. Similarly, using subject-interval records with Z = 1 and Sk = 1, obtain ηˆH by fitting
a pooled logistic regression model (55) with dependent variable Hk and independent
variables a specified function of k = 0, . . . , K and Lk, corresponding to the choice of
φH(·).
3. For all z ∈ Z, set α0(z, 1, ηˆ) and β0(z, 1, ηˆ) to 1. Obtain α1(z, 1, ηˆ), ℵB,1(z), and iB,1(z)
by evaluating the estimated analogues of expression (70), (64), and (66), noting that
P (Bgz+1 = 1) is defined by the intervention, and taking pˆiB,1(z, ηˆ to be the proportion
of individuals with B1 = 1,
1
n
∑n
i=1Bi,1, and noting that pˆiR,1(z, ηˆ) = 1 by definition.
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4. For each subject’s line 1, attach the suspected-superior treatment weight, WB,1, cal-
culated as:

(α1(Z,R1)×expit{φB(1,L1;ηˆB)})B1×(1−αj(Z,R1)×expit{φB(1,L1;ηˆB)})1−B1(
expit{φB(1,L1;ηˆB)}
)B1
×
(
1−expit{φB(1,L1;ηˆB)}
)1−B1
iB,1(Z)
×
(1−α1(Z,R1)×(1−expit{φB(1,L1;ηˆB)}))B1×(αj(Z,R1)×(1−expit{φB(1,L1;ηˆB)}))1−B1(
expit{φB(1,L1;ηˆB)}
)B1
×
(
1−expit{φB(1,L1;ηˆB)}
)1−B1
(1−iB,1(Z))

.
5. For all z ∈ Z, s1 ∈ {0, 1}, then obtain β1(z, s1, ηˆ), ℵH,1(z), and iH,1(z).
6. For each subject’s line 1, attach the suspected-inferior treatment weight, WH,1, calcu-
lated as:

(β1(Z,S1)×expit{φH(1,L1;ηˆH)})H1×(1−β1(Z,S1)×expit{φH(1,L1;ηˆH)})1−H1(
expit{φH(1,L1;ηˆH)}Big)H1×
(
1−expit{φH(1,L1;ηˆH)}
)1−H1
iH,1(Z)
×
(1−β1(Z,S1)×(1−expit{φH(1,L1;ηˆH)}))B1×(β1(Z,S1)×(1−expit{φH(1,L1;ηˆH)}))1−H1(
expit{φH(1,L1;ηˆH)}
)H1
×
(
1−expit{φH(1,L1;ηˆH)}
)1−H1
(1−iH,1(Z))

.
7. Iterate from k = 2, . . . K:
7.1. For all z ∈ Z, rk ∈ {0, 1}, obtain αk(z, rk, ηˆ), ℵB,k(z), and iB,k(z).
7.2. Using subject-interval records on line k, attach the suspected-superior treatment
weight, WB,k, calculated as:
k∏
j=1

(αj(Z,Rj)×expit{φB(j,Lj ;ηˆB)})Bj×(1−αj(Z,Rj)×expit{φB(j,Lj ;ηˆB)})1−Bj(
expit{φB(j,Lj ;ηˆB)}
)Bj
×
(
1−expit{φB(j,Lj ;ηˆB)}
)1−Bj
iB,j(Z)
×
(1−αj(Z,Rj)×(1−expit{φB(j,Lj ;ηˆB)}))Bj×(αj(Z,Rj)×(1−expit{φB(j,Lj ;ηˆB)}))1−Bj(
expit{φB(j,Lj ;ηˆB)}
)Bj
×
(
1−expit{φB(j,Lj ;ηˆB)}
)1−Bj
(1−iB,j(Z))

.
7.3. For all z ∈ Z, sk ∈ {0, 1}, obtain βk(z, sk, ηˆ), ℵH,k(z), and iH,k(z).
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7.4. Using subject-interval records on line k, attach the suspected-superior treatment
weight, WH,k, calculated as:
k∏
j=1

(βj(Z,Sj)×expit{φH(j,Lj ;ηˆH)})Hj×(1−βj(Z,Sj)×expit{φH(j,Lj ;ηˆH)})1−Hj(
expit{φH(j,Lj ;ηˆH)}Big)Hj×
(
1−expit{φH(j,Lj ;ηˆH)}
)1−Hj
iH,j(Z)
×
(1−βj(Z,Sj)×(1−expit{φH(j,Lj ;ηˆH)}))Bj×(βj(Z,Sj)×(1−expit{φH(j,Lj ;ηˆH)}))1−Hj(
expit{φH(j,Lj ;ηˆH)}
)Hj
×
(
1−expit{φH(j,Lj ;ηˆH)}
)1−Hj
(1−iH,j(Z))

.
8. Using all subject-interval records in the cloned dataset, obtain ψˆ by fitting a weighted
pooled logistic regression model, with weights WB,k and WH,k defined in the previous
steps, dependent variable Yk and independent variables a specified function of k =
1, . . . , K and (Z, V ) corresponding to the choice of γ(·).
Our final IPW estimate of the g-formula for the risk of death by K under regime gz,
f gzYK (1) defined by the arbitrary proportionally-representative interventions that constrain
resources can then be obtained by the plug-in estimator of expression (56) in the main text.
8.4. Appendix A proofs
Lemma 1. If P (Bgz+j = 1) ≤ P (Bj = 1) and P (Hgz+j = 1) ≤ P (Hk = 1) for all j ∈
{1, . . . , k}, αj(z) and βj(z) are defined as in expressions (11) and (12), and the identification
conditions of expressions (17)-(24) hold, then P (Bk+1 = 1) ≤ P (Rgz+k+1 = 1) and P (Hk+1 =
1) ≤ P (Sgz+k+1 = 1) for all k ∈ {1, . . . , K}.
Proof. Since P (Bgz+1 = 1) ≤ P (B1 = 1) and P (Bgz1 = 1) = P (B1 = 1) by consistency (since
Bgz1 occurs prior to any intervention) then α1(z) ≤ 1. Then, comparing the terms in
f gzH1(1) =
∑
l1
P (H1 = 1 | L1 = l1, S1 = 1)
(
1− α1(z)× fB1|R1,L1(1 | 1, l1)
)
P (L1 = l1)
with the terms in
P (H1 = 1) =
∑
l1
P (H1 = 1 | L1 = l1, S1 = 1)
(
1− fB1|R1,L1(1 | 1, l1)
)
P (L1 = l1)
We see that f gzH1(1) ≤ P (H1 = 1) whenever α1(z) ≤ 1. Since α1(z) ≤ 1, as shown above,
then β1(z) ≤ 1.
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Similarly, comparing the terms in f gzBk(1) with the terms in
P (Bk = 1) =
∑
lk
P (Bk = 1 | Lk = lk, Rk = 1)
×
k∏
m=1
{
P (Lm = lm | Rm = 1, Lm−1 = lm−1)
× P (Ym−1 = 0 | Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
× (1− fHm−1|Sm−1,Lm−1(1 | 1, lm−1))
× (1− fBm−1|Rm−1,Lm−1(1 | 1, lm−1))},
and likewise comparing the terms in f gzHk(1), we see that f
gz
Bk
(1) ≤ P (Bk = 1) whenever
αm(z) ≤ 1 and βm(z) ≤ 1 for m = 1, . . . , k − 1. Similarly, f gzHk(1) ≤ P (Hk = 1). Arguing,
iteratively, as before, from k = 2, ..., K, and using identification conditions of expressions
(17)-(24) so that f gzHk(1) = P (H
gz
k = 1) and f
gz
Bk
(1) = P (Bgzk = 1), we see that αk(z) ≤ 1 and
βk(z) ≤ 1 for all k ∈ {2, ..., K}.
Then, since the above suffices to show that P (Bgz+k = 1) ≤ P (Bgzk = 1) and P (Hgz+k =
1) ≤ P (Hgzk = 1) for all k ∈ {1, ..., K}, and since P (Bgzk = 1) ≤ P (Rgz+k = 1) and
P (Hgzk = 1) ≤ P (Sgz+k = 1) for all k ∈ {1, ..., K} by definition, then it follows that P (Bgz+k =
1) ≤ P (Rgz+k = 1) and P (Hgz+k = 1) ≤ P (Sgz+k = 1) for all k ∈ {1, ..., K}.
.
Corollary 1. . If P (Bgz+k = 1) ≤ P (Bk = 1) and P (Hgz+k = 1) ≤ P (Hk = 1) for
all k ∈ {1, . . . , K}, αk(z) and βk(z) are defined as in expressions (11) and (12), and the
identification conditions of expressions (17)-(24) hold, then 0 ≥ P (Bgz+k = 1) ≤ 1 and
0 ≥ P (Hgz+k = 1) ≤ 1 for all k ∈ {1, . . . , K}.
Proof. This follows trivially from Theorem 1, since P (Sgz+k = 1) ≤ 1 and P (Rgz+k = 1) ≤ 1
and since all terms used to iteratively define P (Bgz+k = 1) and P (H
gz+
k = 1) are positive.
.
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9. Appendix B: Proving constraint satisfaction
The constraint is satisfied for all intervals t ∈ {1, . . . , K} if
E
[
W gzB,tW
gz
H,t−1Bt
]
= P (Bgz+t = 1)
and
E
[
W gzH,tW
gz
H,tHt
]
= P (Hgz+t = 1)
for all t ∈ {1, . . . , K}
We demonstrate constraint satisfaction for joint intervention on B1 and H1, and leave
the rest of the proof for the reader.
9.1. Suspected inferior treatment utlization in interval 1 under regime gz, after intervention
(i.e., Bgz+1 )
Substitute expression for weights:
E
[
W
gz
B,1
B1
]
=E

((
α1(z,R1)P (B1=1|R1,L1)
)B1(
1−α1(z,R1)P (B1=1|R1,L1)
)(1−B1)(
P (B1=1|R1,L1)
)B1(
1−P (B1=1|R1,L1)
)(1−B1)
)igz
B,1
×
((
1−α1(z,R1)(1−P (B1=1|R1,L1))
)B1(
α1(z,R1)(1−P (B1=1|R1,L1))
)(1−B1)(
P (B1=1|R1,L1)
)B1(
1−P (B1=1|R1,L1)
)(1−B1)
)(1−igz
B,1
)
× B1

Substitute expression for α1(z,R1):
= E


[( qgz1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

B1
×

1−
[(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

igz
B,1
×


1−
[(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

B1
×
[( qgz1 ×P (B1=1)
P (B
gz
1 =0)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

(1−igz
B,1
)
× B1

Evaluating total expectation, conditional on R1 and L1. Since B1 is binary, terms expo-
nentiated by (1 − B1) drop out of the sum, and since B1 = 1 implies R1 = 1, then terms
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exponentiated by R1 are retained and the R1 exponent is dropped. Furthermore, terms ex-
ponentiated by the indicator functions (1− igzB,1) that are themselves exponentiated by the
indicator functions igzB,1, and vice versa, are removed, as are the inner indicator functions
that themselves agree with the outer indicator functions. Finally, the alpha term is removed
from terms themselves exponentiated by igzB,1 (since i
gz
B,1 = 1 implies ℵgzB,1 = 1).
=
∑
l1


(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)
×P (B1=1|R1=1,l1)
P (B1=1|R1=1,l1)

igz
B,1
×
 1−
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)
×
(
ℵgz
B,1
)
P (B1=0|R1=1,l1)
P (B1=1|R1=1,l1)

(1−igz
B,1
)
× P (B1 = 1 | R1 = 1, l1)P (R1 = 1 | l1)P (L1 = l1)

Since by consistency Bgz1 = B1 and R
gz+
1 = R1 = 1, then,
=
∑
l1


(
q
gz
1 ×P (B1=1)
P (B1=1)
)
×P (B1=1|l1)
P (B1=1|l1)

igz
B,1
×
 1−
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
(
ℵgz
B,1
)
P (B1=0|l1)
P (B1=1|l1)

(1−igz
B,1
)
× P (B1 = 1 | l1)P (L1 = l1)

Re-arranging and cancelling terms,
=
∑
l1

(
q
gz
1 ×
)igz
B,1
×
 1−
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
(
ℵgz
B,1
)
P (B1=0|l1)
P (B1=1|l1)

(1−igz
B,1
)
× P (B1 = 1 | l1)P (L1 = l1)

Noting that when igzB,1 = 0 and ℵgzB,1 = 1:
E
[
W
gz
B,1
B1
]
=
∑
l1

(
1−
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
× P (B1 = 0 | l1)
)
× P (L1 = l1)

=
∑
l1
{
P (L1 = l1)−
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
× P (B1 = 0 | l1)P (L1 = l1)
}
=1− (1− qgz1 × P (B1 = 1))
=q
gz
1 × P (B1 = 1)
Therefore,
1. If igzB,1 = 1 then E
[
W gzB,1B1
]
= qgz1 × E[B1] and
2. If igzB,1 = 0 and ℵgzB,1 = 1 then E
[
W gzB,1B1
]
= qgz1 × E[B1]
3. If igzB,1 = 0 and ℵgzB,1 = 0 then E
[
W gzB,1B1
]
= E[R1] = E[Rgz+1 ]
And so the constraint is satisfied.
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9.2. Natural suspected inferior treatment utilization in interval 1 under regime gz (i.e., H
gz
1 )
Substitute expression for weights and α1(z,R1):
E
[
W
gz
B,1
H1
]
=E


[( qgz1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

B1
×

1−
[(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

igz
B,1
×


1−
[(
P (B
gz
1 =1)
P (B
gz
1 =1)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

B1
×
[( qgz1 ×P (B1=1)
P (B
gz
1 =0)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

(1−igz
B,1
)
× H1

Evaluating total expectation, conditional on B1, R1 and L1. Since H1 is binary, and
since H1 = 1 implies B1 = 0 and R1 = 1, then terms exponentiated by B1 drop out of
the sum, and terms exponentiated by R1 are retained and the R1 exponent is dropped. As
in previous steps, terms exponentiated by indicator functions are removed or retained, as
appropriate.
=
∑
l1

 1−
(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)
P (B1=1|R1=1,l1)
P (B1=0|R1=1,l1)

igz
B,1
×

( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)
×
(
ℵgz
B,1
)
P (B1=0|R1=1,l1)
P (B1=0|R1=1,l1)

(1−igz
B,1
)
× P (H1 = 1 | B1 = 0, R1 = 1, l1)P (B1 = 0 | R1 = 1, l1)P (R1 = 1 | l1)P (L1 = l1)

Since by consistency Bgz1 = B1 and R
gz+
1 = R1 = 1, and re-arranging and cancelling
terms:
=
∑
l1

(
1− qgz1 × P (B1 = 1 | l1)
)igz
B,1
×
(
1−qgz1 ×P (B1=1)
P (B1=0)
(
ℵgz
B,1
)
P (B1 = 0 | l1)
)(1−igz
B,1
)
× P (H1 = 1 | B1 = 0, l1)P (L1 = l1)

Noting that when igzB,1 = 0 and ℵgzB,1 = 1, then
E
[
W
gz
B,1
H1
]
=
∑
l1

(
1−qgz1 ×P (B1=1)
P (B1=0)
P (B1 = 0 | l1)
)
× P (H1 = 1 | B1 = 0, l1)P (L1 = l1)

=
1− qgz1 × P (B1 = 1)
P (B1 = 0)
P (H1 = 1)
=
1− qgz1 × P (B1 = 1)
P (B1 = 0)
P (H1 = 1 | B = 0)P (B1 = 0)
=P (H1 = 1 | B1 = 0)(1− qgz1 × P (B1 = 1))
=(1− qgz1 ×)P (H1 = 1 | B1 = 0) + q
gz
1 × P (H1 = 1)
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Noting that when igzB,1 = 1 and ℵgzB,1 = 1, then
E
[
W
gz
B,1
H1
]
=
∑
l1
{
P (H1 = 1 | B1 = 0, L1 = l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)
}
=
 (1− q
gz
1 ×)
∑
l1
{
P (H1 = 1 | B1 = 0, L1 = l1)P (L1 = l1)
}
+q
gz
1 × P (H1 = 1)

Therefore,
4. If igzB,1 = 1 and ℵgzB,1 = 1 then:
E
[
W
gz
B,1
H1
]
=
∑
l1
{
P (H1 = 1 | B1 = 0, L1 = l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)
}
5. If igzB,1 = 0 and ℵgzB,1 = 1 then:
E
[
W
gz
B,1
H1
]
= P (H1 = 1 | B1 = 0)
(
1− qgz1 × P (B1 = 1)
)
6. If igzB,1 = 0 and ℵgzB,1 = 0 then:
E
[
W
gz
B,1
H1
]
= 0
9.3. Suspected inferior treatment utilization in interval 1 under regime gz, after intervention
(i.e., Hgz+1 )
Substitute expression for weights, α1(z,R1) and β1(z, S1).
E
[
W
gz
B,1
W
gz
H,1
H1
]
=E


[( qgz1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

B1
×

1−
[(
q
gz
1 ×P (B1=1)
P (B
gz
1 =1)
)igz
B,1
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)(
ℵgz
B,1
)]R1
P (B1 = 1 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

igz
B,1
×


1−
[(
P (B
gz
1 =1)
P (B
gz
1 =1)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

B1
×
[( qgz1 ×P (B1=1)
P (B
gz
1 =0)
)igz
B,1
×
( 1− qgz1 ×P (B1=1)
P (R
gz+
1 =1)
P (B
gz
1 =0|R
gz+
1 =1)
)(1−igz
B,1
)
×
(
ℵgz
B,1
)]R1
P (B1 = 0 | R1, L1)

(1−B1)
× 1
P (B1=1|R1,L1)B1P (B1=0|R1,L1)(1−B1)

(1−igz
B,1
)
×

[(mgz1 ×P (H1=1)
P (H
gz
1 =1)
)igz
H,1
( 1−mgz1 ×P (H1=1)
P (R
gz+
1 =1)
P (H
gz
1 =0|S
gz+
1 =1)
)(1−igz
H,1
)(
ℵgz
H,1
)]S1
P (H1 = 1 | S1, L1)

H1
×

1−
[(
m
gz
1 ×P (H1=1)
P (H
gz
1 =1)
)igz
H,1
( 1−mgz1 ×P (H1=1)
P (R
gz+
1 =1)
P (H
gz
1 =0|R
gz+
1 =1)
)(1−igz
H,1
)(
ℵgz
H,1
)]S1
P (H1 = 1 | S1, L1)

(1−H1)
× 1
P (H1=1|S1,L1)H1P (H1=0|S1,L1)(1−H1)

igz
H,1
×


1−
[(
P (H
gz
1 =1)
P (H
gz
1 =1)
)igz
H,1
×
( 1−mgz1 ×P (H1=1)
P (R
gz+
1 =1)
P (H
gz
1 =0|S
gz+
1 =1)
)(1−igz
H,1
)
×
(
ℵgz
H,1
)]S1
P (H1 = 0 | S1, L1)

H1
×
[(mgz1 ×P (H1=1)
P (H
gz
1 =0)
)igz
H,1
×
( 1−mgz1 ×P (H1=1)
P (R
gz+
1 =1)
P (H
gz
1 =0|S
gz+
1 =1)
)(1−igz
H,1
)
×
(
ℵgz
H,1
)]S1
P (H1 = 0 | S1, L1)

(1−H1)
× 1
P (H1=1|S1,L1)H1P (H1=0|S1,L1)(1−H1)

(1−igz
H,1
)
× H1

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Evaluating total expectation, conditional on B1, R1 and L1. Since H1 is binary, and since
H1 = 1 implies S1 = 1, B1 = 0 and R1 = 1, then terms exponentiated by (1−S1) and by B1
drop out of the sum, and terms exponentiated by R1 and S1 are retained and the R1 and
S1 exponents are dropped. As in previous steps, terms exponentiated by indicator functions
are removed or retained, as appropriate. Noting also that Bgz1 = B1 and R
gz+
1 = R1 = 1,
then,
=
∑
l1

 1−
(
q
gz
1 ×P (B1=1)
P (B1=1)
)
P (B1=1|l1)
P (B1=0|l1)

igz
B,1
×

(
1−qgz1 ×P (B1=1)
P (B1=1)
)
×
(
ℵgz
B,1
)
P (B1=0|l1)
P (B1=0|l1)

(1−igz
B,1
)
×

(
m
gz
1 ×P (H1=1)
P (H
gz
1 =1)
)
P (H1=1|B1=0,l1)
P (H1=1|B1=0,l1)

igz
H,1
×
 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =1)
P (H
gz
1 =0|B
gz
1 =0)
)
×
(
ℵgz
H,1
)
P (H1=0|B1=0,l1)
P (H1=1|B1=0,l1)

(1−igz
H,1
)
× P (H1 = 1 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)

Noting that P (H1 = 1 | B1 = 0) = P (H1=1)P (B1=0) , and re-arranging terms and cancelling some
terms as in previous steps.
=
∑
l1

(
1−qgz1 ×P (B1=1|l1)
P (B1=0|l1)
)igz
B,1
×
((
1−qgz1 ×P (B1=1))
P (B1=0)
)
×
(
ℵgz
B,1
))(1−igz
B,1
)
×

(
m
gz
1 ×P (H1=1)
P (H
gz
1 =1)
)
P (H1=1|B1=0,l1)
P (H1=1|B1=0,l1)

igz
H,1
×
 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =0)
1−P (H
gz
1 =1)
P (B
gz
1 =0)
)
×
(
ℵgz
H,1
)
P (H1=0|B1=0,l1)
P (H1=1|B1=0,l1)

(1−igz
H,1
)
× P (H1 = 1 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)

Noting that when igzB,1 = 1 and i
gz
H,1 = 1, then
E
[
W
gz
B,1
W
gz
H,1
H1
]
=
∑
l1

(
1−qgz1 ×P (B1=1|l1)
P (B1=0|l1)
)
×
 m
gz
1 ×P (H1=1)∑
l1
 P (H1 = 1 | B1 = 0, L1 = l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)


× P (H1 = 1 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)

=
∑
l1

 m
gz
1 ×P (H1=1)∑
l1
 P (H1 = 1 | B1 = 0, L1 = l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)


× P (H1 = 1 | B1 = 0, l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)

=m
gz
1 × P (H1 = 1)
Noting that when igzB,1 = 1 and i
gz
H,1 = 0 and ℵgzH,1 = 1, then
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1− m
gz
1 ×P (H1=1)
P (B
gz
1 =0)
1− P (H
gz
1 =1)
P (B
gz
1 =0)
=
1− m
gz
1 ×P (H1=1)
1−qgz1 ×P (B1=1)
1−
∑
l1
 P (H1 = 1 | B1 = 0, L1 = l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)

1−qgz1 ×P (B1=1)
=
1− qgz1 × P (B1 = 1)−m
gz
1 × P (H1 = 1)
1− qgz1 × P (B1 = 1)− (1− q)
∑
l1
{P (H1 = 1 | B1 = 0, L1 = l1)P (L1 = l1)} − qgz1 × P (H1 = 1)
And thus:
E
[
W
gz
B,1
W
gz
H,1
H1
]
=
∑
l1

 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =1)
1−P (H
gz
1 =1)
P (B
gz
1 =1)
)
×P (H1=0|B1=0,l1)
P (H1=1|B1=0,l1)

× P (H1 = 1 | B1 = 0, l1)
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)

=
∑
l1

 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =1)
1−P (H
gz
1 =1)
P (B
gz
1 =1)
)
× P (H1 = 0 | B1 = 0, l1)

×
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)

=
∑
l1
{
×
(
1− qgz1 × P (B1 = 1 | l1)
)
P (L1 = l1)
}
−
∑
l1

 1−
m
gz
1 ×P (H1=1)
P (B
gz
1 =1)
1−P (H
gz
1 =1)
P (B
gz
1 =1)

×
(
1− P (H1 = 1 | B1 = 0, l1)
)(
(1− qgz1 ×) + q
gz
1 × P (B1 = 0 | l1)
)
P (L1 = l1)

=
(
1− qgz1 × P (B1 = 1)
)
−
∑
l1

(
1−qgz1 ×P (B1=1)−m
gz
1 ×P (H1=1)
1−qgz1 ×P (B1=1)−(1−q)
∑
l1
{P (H1=1|B1=0,L1=l1)P (L1=l1)}−qgz1 ×P (H1=1)
)
×
 (1− qgz1 × P (B1 = 1))− (1− qgz1 ×)∑l1 P (H1 = 1 | B1 = 0, L1 = l1)P (L1 = l1)
− qgz1 × P (H1 = 1)


=
(
1− qgz1 × P (B1 = 1)
)
− (1− qgz1 × P (B1 = 1)−mgz1 × P (H1 = 1))
=m
gz
1 × P (H1 = 1)
Noting that when igzB,1 = 0 and i
gz
H,1 = 0 and ℵgzH,1 = 1, then
1− m
gz
1 ×P (H1=1)
P (B
gz
1 =0)
1− P (H
gz
1 =1)
P (B
gz
1 =0)
=
1− m
gz
1 ×P (H1=1)
1−qgz1 ×P (B1=1)
1− P (H1=1|B1=0)(1−q
gz
1 ×P (B1=1))
1−qgz1 ×P (B1=1)
=
1− qgz1 × P (B1 = 1)−m
gz
1 × P (H1 = 1)
1− qgz1 × P (B1 = 1)− (1− q
gz
1 ×)P (H1 = 1 | B1 = 0)− q
gz
1 × P (H1 = 1)
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=
1− qgz1 × P (B1 = 1)−m
gz
1 × P (H1 = 1)
P (H1 = 0 | B1 = 0)(1− qgz1 × P (B1 = 1))
Thus:
E
[
W
gz
B,1
W
gz
H,1
H1
]
=
∑
l1

((
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
)
×
 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =0)
1−P (H
gz
1 =1)
P (B
gz
1 =0)
)
×P (H1=0|B1=0,l1)
P (H1=1|B1=0,l1)

× P (H1 = 1 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)

=
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
∑
l1

 1−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =0)
1−P (H
gz
1 =1)
P (B
gz
1 =0)
)
× P (H1 = 0 | B1 = 0, l1)

× P (B1 = 0 | l1)P (L1 = l1)

=
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
∑
l1

 P (B1 = 0 | l1)P (L1 = l1)−
( 1−mgz1 ×P (H1=1)
P (B
gz
1 =0)
1−P (H
gz
1 =1)
P (B
gz
1 =0)
)
× P (H1 = 0 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)


=
(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
(
P (B1 = 0)− P (H1 = 0)
1−qgz1 ×P (B1=1)−m
gz
1 ×P (H1=1)
P (H1=0|B1=0)(1−qgz1 ×P (B1=1))
)
=
(
1− qgz1 × P (B1 = 1)− (1− q
gz
1 × P (B1 = 1))P (H1 = 0)
1−qgz1 ×P (B1=1)−m
gz
1 ×P (H1=1)
P (H1=0|B1=0)P (B1=0)(1−qgz1 ×P (B1=1))
)
=
(
1− qgz1 × P (B1 = 1)− (1− q
gz
1 × P (B1 = 1))P (H1 = 0)
1−qgz1 ×P (B1=1)−m
gz
1 ×P (H1=1)
P (H1=0)(1−qgz1 ×P (B1=1))
)
=
(
1− qgz1 × P (B1 = 1)−
(
1− qgz1 × P (B1 = 1)−m
gz
1 × P (H1 = 1)
))
=m
gz
1 × P (H1 = 1)
Noting that when igzB,1 = 0 and i
gz
H,1 = 1 and ℵgzH,1 = 1, then
E
[
W
gz
B,1
W
gz
H,1
H1
]
=
∑
l1

(
1−qgz1 ×P (B1=1|R1=1))
P (B1=0|R1=1)
)
×
(
m
gz
1 ×P (H1=1)
P (H
gz
1 =1)
)
× P (H1 = 1 | B1 = 0, l1)P (B1 = 0 | l1)P (L1 = l1)

=

(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
(
m
gz
1 ×P (H1=1)
P (H
gz
1 =1)
)
× P (H1 = 1)

=

(
1−qgz1 ×P (B1=1)
P (B1=0)
)
×
(
m
gz
1 ×P (H1=1)
P (H1=1|B1=0)
(
1−qgz1 ×P (B1=1)
))
× P (H1 = 1)

=

(
1− qgz1 × P (B1 = 1)
)
×
(
m
gz
1 ×P (H1=1)
P (H1=1)
(
1−qgz1 ×P (B1=1)
))
× P (H1 = 1)

=m
gz
1 × P (H1 = 1)
Therefore:
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1. If igzB,1 = 1 and iH1 = 1 then E
[
W gzB,1W
gz
H,1H1
]
= mgz1 × E[H1] and
2. If igzB,1 = 0 and iH1 = 1 then E
[
W gzB,1W
gz
H,1H1
]
= mgz1 × E[H1] and
3. If igzB,1 = 1 and iH1 = 0 and ℵgzH,1 = 1 then E
[
W gzB,1W
gz
H,1H1
]
= mgz1 × E[H1] and
4. If igzB,1 = 0 and and ℵgzB,1 = 1 igzB,1 = 0 then E
[
W gzB,1W
gz
H,1H1
]
= mgz1 × E[H1] and
5. If ℵgzB,1 = 0 then E
[
W gzB,1W
gz
H,1H1
]
= 0 and
6. If ℵgzH,1 = 0 then E
[
W gzB,1W
gz
H,1H1
]
= P (Bgz1 = 0) = E(S
gz
1 = 1)
And so the constraint is satisfied.
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10. Appendix C: Relationship between proportionally-representative interven-
tions and deterministic regimes
Section 2 of Young, et. al (2014) [6] provides a succinct review of the relationship
between deterministic and random (i.e. stochastic) regimes. Specifically, a regime gz can be
considered deterministic for some treatment Bk with support B, if the following condition
holds for all k:
∃ bk ∈ B s.t. fBgz+k |Lgzk ,Rgz+k (ak | Lk, Rk) = 1, w.p.1.
In words, a regime gz can be considered deterministic if every individual, possibly con-
ditional on their treatment and covariate history, receives some treatment with certainty
under the regime. Otherwise, a regime is stochastic, when at least one individual, possibly
conditional on their treatment and covariate history, could possibly receive more than one
treatment level under the regime.
Obviously, proportionally representative interventions are always stochastic, unless one
the following condition holds for all k:
qgzk × P (Bk = 1) > P (Rgz+k = 1), (88)
or
qgzk × P (Hk = 1) = 0. (89)
In words the former condition means that there are more treatment resources available
than their are treatment eligible individuals, and the latter condition means that there are
no treatment resources available under regime gz. If the former condition holds, for a par-
ticular k, then all eligible individuals will receive the treatment with certainty. We refer
to this condition as one in which treatment resources are ‘practically unlimited’. If the
latter condition holds, for a particular k, then all individuals will receive no treatment with
certainty. We refer to this condition as one in which treatment resources are ‘abolished’.
Under these conditions, proportionally representative interventions are static deterministic
interventions, according to the definitions in Young, et. al (2014) [6]. As such, an expected
potential outcome under an arbitrary deterministic regime can be understood as a pro-
portionally representative intervention in which treatment resources are either abolished or
made practically unlimited for each subgroup of the target population. As a consequence,
we can appreciate that the average outcome observed in one arm of an ideal randomized
controlled trial, where participants are deterministically assigned treatment A = a, identifies
the average potential outcome under a proportionally representative intervention in which
treatment level A = a is made to be practically unlimited for all subgroups. When such an
intervention on treatment resources is not feasible, then that estimand will not be relevant
for policy-making.
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11. Appendix D: G-formula proof
Here we provide a proof for the identification formula for expected potential outcomes
under proportionally-representative interventions for limited resources, under the ’natural
course’ - that is, under an additional hypothetical intervention to prevent censoring in all
individuals (i.e. cK = 0). Thus, our proof also covers settings in which censoring can be
present, and so we generalize the identifiability conditions from the main text to allow for
censoring. Let Ck be an indicator for censoring in interval k. By definition, all individuals
are uncensored in interval 0, so C0 = 0, and individuals that had previously been censored,
stay censored, such that if Ck = 1 then Ck = 1. We define a topological order within each
interval that includes censoring as
(
Lk, Bk, Hk, Ck, Yk
)
. Further, we redefine all regimes gz,
z ∈ Z to involve some proportionally-representative intervention, and an intervention on
C
gz
K such that C
gz+
K = 0 for all individuals.
Finally, for the sake of the proof, we consider the stochastic regime gz for Bk, defined
by the intervention density fBgz+k |L
gz
k ,R
gz+
k ,C
gz+
k−1
(· | ·) to be produced by some deterministic
regime g−z , so that B
gZ+
k = g
−
z,B,k(L
gz
k , R
gz+
k , C
gz+
k−1, V
gz
B,k), and thus:
fBgz+k |L
gz
k ,R
gz+
k ,C
gz+
k−1 ,V
gz
B,k
(Bgz+k | L
gz
k , R
gz+
k , C
gz+
k−1, V
gz
B,k) =
I(Bgz+k = g
−
z,B,k(L
gz
k , R
gz+
k , C
gz+
k−1, V
gz
B,k),
and where V gzk is completely exogenous with respect to all other variables in the observed
data, and g−z,k(·) is specified precisely so that:∫
vB,k
I(Bgz+k = g
−
z,B,k(L
gz
k , R
gz+
k , C
gz+
k−1, vB,k))fV gzB,k(vB,k) = (90)
fBgz+k |L
gz
k ,R
gz+
k ,C
gz+
k−1
(Bgz+k | L
gz
k , R
gz+
k , C
gz+
k−1).
That is, under regime gz, the suspected inferior treatment, B
gZ+
k is assigned a value as a
deterministic function of {Lgzk , Rgz+k , Cgz+k−1, V gzB,k} according to g−z,k(·), and g−z,k(·) is precisely
specified such that marginalizaing over the joint distribution of BgZ+k and V
gz
B,k, conditional
on past treatment and covariate history, equals the defining intervention distribution of the
stochastic intervention. Likewise, there exist V gzB,k and V
gz
H,k with these properties for all
k = 0, . . . , K.
11.1. Exchangeability 1
Y gzt ⊥ I(Bgzt = bt) | Lgzt = lt, Cgzt−1 = Y gzt−1 = 0, Hgzt−1 = ht−1, Bgzt−1 = bt−1, (91)
for {bt, lt, ht−1 | P (Bgz+ = bt, Lgzt = lt, Cgz+t−1 = Y gzt−1 = 0, Hgz+t−1 = ht−1) > 0}, t ∈
{1, . . . , k}, and:
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Y gzt ⊥ I(Hgzt = ht) | Bgzt = bt, Lgzt = lt, Cgzt−1 = Y gzt−1 = 0, Hgzt−1 = ht−1, (92)
for {ht, bt, lt | P (Hgz+t = ht, Bgz+t = bt, Lgzt = lt, Cgz+t−1 = Y gzt−1 = 0) > 0}, t ∈ {1, . . . , k},
and:
Y gzt ⊥ I(Cgzt = 0) | Hgzt = ht, Bgzt = bt, Lgzt = lt, Y gzt−1 = Cgzt−1 = 0, (93)
for {ht, bt, lt | P (Hgz+t = ht, Bgz+t = bt, Lgzt = lt, Cgz+t = Y gzt−1 = 0) > 0}, t ∈ {1, . . . , k}.
Sequential exchangeability conditions for the outcomes Yt, with respect to past treatment,
in the main text are extended to include sequential exchangeability with respect to censoring.
11.2. Exchangeability 2
Bgzt ⊥ I(Bgzt−1 = bt−1) | Lgzt−1 = lt−1, Cgzt−2 = Y gzt−2 = 0, Hgzt−2 = ht−2, Bgzt−2 = bt−2, (94)
for {bt−1, lt−1, ht−2 | P (Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−2 = Y gzt−2 = 0, Hgz+t−2 = ht−2) > 0},
t ∈ {1, . . . , k}, and:
Bgzt ⊥ I(Hgzt−1 = ht−1) | Bgzt−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−2 = Y gzt−2 = 0, Hgzt−2 = ht−2, (95)
for {ht−1, bt−1, lt−1 | P (Hgz+t−1 = ht−1, Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−2 = Y gzt−2 = 0) > 0},
t ∈ {1, . . . , k}, and:
Bgzt ⊥ I(Cgzt−1 = 0) | Hgzt−1 = ht−1, Bgzt−1 = bt−1, Lgzt−1 = lt−1, Y gzt−2 = Cgzt−2 = 0, (96)
for {ht−1, bt−1, lt−1 | P (Hgz+t−1 = ht−1, Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−1 = Y gzt−2 = 0) > 0},
t ∈ {1, . . . , k}, and:
Hgzt ⊥ I(Bgzt = bt) | Lgzt = lt, Cgzt−1 = Y gzt−1 = 0, Hgzt−1 = ht−1, Bgzt−1 = bt−1, (97)
for {bt, lt, ht−1 | P (Bgz+t = bt, Lgzt = lt, Cgz+t−1 = Y gzt−1 = 0, Hgz+t−1 = ht−1) > 0}, t ∈
{1, . . . , k}, and:
49
Hgzt ⊥ I(Hgzt−1 = ht−1) | Bgzt−1 = bt−1, Lgzt−1 = lt−1, Cgzt−2 = Y gzt−2 = 0, Hgzt−2 = ht−2, (98)
for {ht−1, bt−1, lt−1 | P (Hgz+t−1 = ht−1, Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−2 = Y gzt−2 = 0) > 0},
t ∈ {1, . . . , k}, and:
Hgzt ⊥ I(Cgzt−1 = 0) | Hgzt−1 = ht−1, Bgzt−1 = bt−1, Lgzt−1 = lt−1, Cgzt−2 = Y gzt−2 = 0, (99)
for {ht−1, bt−1, lt−1 | P (Hgz+t−1 = ht−1, Bgz+t−1 = bt−1, Lgzt−1 = lt−1, Cgz+t−1 = Y gzt−2 = 0) > 0},
t ∈ {1, . . . , k}.
Sequential exchangeability conditions for the treatment resources, with respect to past
treatment, in the main text are extended to include sequential exchangeability with respect
to censoring.
11.3. Consistency
if Bt = B
gz+
t , H t = H
gz+
t and Ct = 0
then Yt = Y
gz
t , Lt+1 = L
gz
t+1, and, and Bt+1 = B
gz
t+1, (100)
and,
if H t = H
gz+
t , Ct = 0, and Bt+1 = B
gz+
t+1
then Ht+1 = H
gz
t+1, (101)
and,
if Ct−1 = 0, Bt = B
gz+
t , and H t = H
gz+
t
then Ck+1 = C
gz
t , (102)
for all t ∈ {0, . . . , K}.
Consistency statements are updated to reflect the additional hypothetical intervention
to prevent censoring.
50
11.4. Positivity
fRgz+t ,L
gz
t ,C
gz+
t−1
(1, Lt, 0) > 0 and fBgz+t |Rgz+t ,L
gz
t ,C
gz+
t−1
(Bt | 1, Lt, 0) > 0 =⇒
fBt|Rt,Lt,Ct−1(Bt | 1, Lt, 0) > 0, w.p.1, (103)
and:
fSgz+t ,L
gz
t ,C
gz+
t−1
(1, Lt, 0) > 0 and fHgz+t |Sgz+t ,L
gz
t ,C
gz+
t−1
(Ht | 1, Lt, 0) > 0 =⇒
fHt|St,Lt,Ct−1(Ht | 1, Lt, 0) > 0, w.p.1, (104)
and:
fSgz+t ,L
gz
t ,C
gz+
t−1
(1, Lt, 0) > 0 =⇒
fCt|St,Lt,Ct−1(0 | 1, Lt, 0) > 0, w.p.1, (105)
Positivity conditions are extended so that if there exists in interval t some censoring-
eligible individuals (alive, untreated, and uncensored) with covariate history lt who are
uncensored under regime gz+, then there must be some such individuals in the unintervened
world.
Theorem 1. If conditions (91)-(105) hold, then E(Y gzK ) is identified from the non-extended
g-formula of Robins (1986) for YK, f
gz
YK
(1): equal to
∑
lK
∑
hK
∑
bK
K∑
k=1
P (Yk = 1 | Ck = 0, Hk = hk, Bk = bk, Lk = lk, Yk−1 = 0) (106)
×
k∏
j=1
{
f
Hgz+j |B
gz+
j ,L
gz
j ,Y
gz
j−1,C
gz+
j−1 ,H
gz+
j−1
(hj | bj, lj, 0, 0, hj−1)
× f
Bgz+j |L
gz
j ,Y
gz
j−1,C
gz+
j−1 ,H
gz+
j−1 ,B
gz+
j−1
(bj | lj, 0, 0, hj−1, bj−1)
× P (Lj = lj | Yj−1 = 0, Cj−1 = 0, Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1)
× P (Yj−1 = 0 | Cj−1 = 0, Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1, Yj−2 = 0)
}
,
where
f
Bgz+j |L
gz
j ,Y
gz
j−1,C
gz+
j−1 ,H
gz+
j−1 ,B
gz+
j−1
(bj | lj, 0, 0, hj−1, bj−1) = (107)(
αj(z)× fBj |Lj ,Yj−1,Cj−1,Hj−1,Bj−1(1 | lj, 0, 0, hj−1, bj−1)
)bj
×
(
1− αj(z)× fBj |Lj ,Yj−1,Cj−1,Hj−1,Bj−1(0 | lj, 0, 0, hj−1, bj−1)
)1−bj
.
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, and
f
Hgz+j |B
gz+
j ,L
gz
j ,Y
gz
j−1,C
gz+
j−1 ,H
gz+
j−1
(hj | bj, lj, 0, 0, hj−1) = (108)(
βj(z)× fHj |Bj ,Lj ,Yj−1,Cj−1,Hj−1(1 | bj, lj, 0, 0, hj−1)
)hj
×
(
1− βj(z)× fHj |Bj ,Lj ,Yj−1,Cj−1,Hj−1(0 | bj, lj, 0, 0, hj−1)
)1−hj
,
and α1(z, 1) is identified by noting the equality P (B
gz
k = 1) = P (Bk = 1), αk(z, Rk)
and αk(z, Sk), are identified by the functionals in expressions (70) and (71), and ℵ and
i indicator functions are identified by the functionals in expressions (64) - (67), except
replacing P (Bgzk = 1) with f
gz
Bk
(1), P (Hgzk = 1) with f
gz
Hk
(1), and P (Rgz+k = 1) with f
gz
Rk
(1)
and P (Sgz+k = 1) with f
gz
Sk
(1), where:
f gzBj(1) =
∑
lj
P (Bj = 1 | Lj = lj, Rj = 1, Cj−1 = 0) (109)
×
j∏
m=1
{
P (Lm = lm | Rm = 1, Cm−1 = 0, Lm−1 = lm−1)
× P (Ym−1 = 0 | Cm−1 = 0, Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
× f
Hgz+m−1|B
gz+
m−1,L
gz
m−1,Y
gz
m−2,C
gz+
m−2,H
gz+
m−2
(0 | bm−1, lm−1, 0, 0, hm−2)
× f
Bgz+m−1|L
gz
m−1,Y
gz
m−2,C
gz+
m−2,H
gz+
m−2,B
gz+
m−2
(0 | lm−1, 0, 0, hm−2, bm−2)
}
,
and:
f gzHj(1) =
∑
lj
P (Hj = 1 | Lj = lj, Sj = 1, Cj−1 = 0) (110)
×
j∏
m=1
{
f
Bgz+m |Lgzm ,Y gzm−1,Cgz+m−1,H
gz+
j−m,B
gz+
m−1
(0 | lj, 0, 0, hm−1, bm−1)
× P (Lm = lm | Rm = 1, Cm−1 = 0, Lm−1 = lm−1)
× P (Ym−1 = 0 | Cm−1 = 0, Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
× f
Hgz+m−1|B
gz+
m−1,L
gz
m−1,Y
gz
m−2,C
gz+
m−2,H
gz+
m−2
(0 | bm−1, lm−1, 0, 0, hm−2)
}
,
and:
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f gzRk(1) =
∑
lk−1
P (Yk−1 = 0 | Ck−1 = 0, Hk−1 = 0, Bk−1 = 0, Lk−1 = lk−1, Yk−2 = 0) (111)
×
k−1∏
m=1
{
f
Hgz+m |Bgz+m ,Lgzm ,Y gzm−1,Cgz+m−1,H
gz+
m−1
(0 | bm, lm, 0, 0, hm−1)
× f
Bgz+m |Lgzm ,Y gzm−1,Cgz+m−1,H
gz+
j−m,B
gz+
m−1
(0 | lj, 0, 0, hm−1, bm−1)
× P (Lm = lm | Rm = 1, Cm−1 = 0, Lm−1 = lm−1)
× P (Ym−1 = 0 | Cm−1 = 0, Hm−1 = 0, Sm−1 = 1, Lm−1 = lm−1)
}
,
and:
f gzSk(1) =
∑
lk
f
Bgz+k |L
gz
k ,Y
gz
k−1,C
gz+
k−1 ,H
gz+
k−1,B
gz+
k−1
(0 | lk, 0, 0, hk−1, bk−1) (112)
× P (Lk = lk | Rk = 1, Ck−1 = 0, Lk−1 = lk−1) (113)
×
k−1∏
m=1
{
P (Ym = 0 | Cm = 0, Hm = 0, Sm = 1, Lm = lm)
× f
Hgz+m |Bgz+m ,Lgzm ,Y gzm−1,Cgz+m−1,H
gz+
m−1
(0 | bm, lm, 0, 0, hm−1)
× f
Bgz+m |Lgzm ,Y gzm−1,Cgz+m−1,H
gz+
j−m,B
gz+
m−1
(0 | lj, 0, 0, hm−1, bm−1)
× P (Lm = lm | Rm = 1, Cm−1 = 0, Lm−1 = lm−1)
}
.
Proof. Assume that conditions (91)-(105) hold. Using laws of probability:
E(Y gzK ) =
K∑
k=1
P (Y gzk = 1 | Y gzk−1 = 0)
k∏
j=1
{
P (Y gzj−1 = 0 | Y gzj−2 = 0)
}
=
K∑
k=1
P (Y gzk = 1, Y
gz
k−1 = 0)
Then E(Y gzK ) is identified if each element of the sum is identified. We provide the proof
for k = 1, and leave the rest for the reader.
Since Y
gz
0 = 0 for all individuals,
P (Y gz1 = 1, Y
gz
0 = 0) = P (Y
gz
1 = 1).
Using laws of probability,
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=
∑
l1
∑
h1
∑
b1
P (Y
gz
1 = 1 | C
gz+
1 = 0, H
gz+
1 = h1, B
gz+
1 = b1, L
gz
1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1
(h1 | b1, l1)
× f
B
gz+
1 |L
gz
1
(b1 | l1)
× P (Lgz1 = l1).
Using the complete exogeneity of V
gz
B,1, and V
gz
H,1, we find that
=
∫
vH,1
∫
vB,1
∑
l1
∑
h1
∑
b1
P (Y
gz
1 = 1 | H
gz+
1 = h1, B
gz+
1 = b1, L
gz
1 = l1, V
gz
H,1
= vH,1, V
gz
B,1
= vB,1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
(h1 | b1, l1, vH,1)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
(b1 | l1, vB,1)f(vB,1)
× P (Lgz1 = l1)
Noting that Bgz+1 and H
gz+
1 are constants conditional on treatment, and covariate histo-
ries and on V gzB,1 and V
gz
H,1, respectively,
=
∫
vH,1
∫
vB,1
∑
l1
∑
h1
∑
b1
P (Y
gz
1 = 1 | L
gz
1 = l1, V
gz
H,1
= vH,1, V
gz
B,1
= vB,1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
(h1 | b1, l1, vH,1)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
(b1 | l1, vB,1)f(vB,1)
× P (Lgz1 = l1)
Using the complete exogeneity of V gzB,1, and V
gz
H,1 again,
=
∫
vB,1
∫
vH,1
∑
l1
∑
h1
∑
b1
P (Y
gz
1 = 1 | L
gz
1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
(h1 | b1, l1, vH,1)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
(b1 | l1, vB,1)f(vB,1)
× P (Lgz1 = l1)
Defining Bgz1,pos × Hgz1,pos × Lgz1,pos = {h1, b1, l1 | P (Hgz+1 = h1, Bgz+1 = b1, Lgz1 = l1) > 0},
that is, the support of Bgz+1 , H
gz+
1 , and L
gz
1 under regime gz, then
=
∫
vB,1
∫
vH,1
∑
Bgz1,pos×H
gz
1,pos×L
gz
1,pos
P (Y
gz
1 = 1 | L
gz
1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
(h1 | b1, l1, vH,1)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
(b1 | l1, vB,1)f(vB,1)
× P (Lgz1 = l1)
Sequentially using the weaker exchangeability conditions with respect to Y gzk for Bk,
Hk, and Ck, of expressions (91) - (93), respectively, and noting that all individuals have
C
gz+
K = 0,
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=∫
vB,1
∫
vH,1
∑
Bgz1,pos×H
gz
1,pos×L
gz
1,pos
P (Y
gz
1 = 1 | C
gz
1 = 0, H
gz
1 = g
−
z,H,1(l1, vB,1, vH,1), B
gz
1 = g
−
z,B,1(l1, vB,1), L
gz
1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
,C
gz+
0
(h1 | b1, l1, vH,1, 0)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
,C
gz+
0
(b1 | l1, vB,1, 0)f(vB,1)
× P (Lgz1 = l1)
Sequentially using the consistency conditions for Lk, Bk, Hk, Ck, and Yk of expressions
(100) and (102), respectively,
=
∫
vB,1
∫
vH,1
∑
l1
∑
h1
∑
b1
P (Y1 = 1 | C1 = 0, H1 = g−z,H,1(l1, vB,1, vH,1), B1 = g
−
z,B,1(l1, vB,1), L1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
,C
gz+
0
(h1 | b1, l1, vH,1, 0)f(vH,1)
× f
B
gz+
1 |L
gz
1 ,V
gz
B,1
,C
gz+
0
(b1 | l1, vB,1, 0)f(vB,1)
× P (L1 = l1)
Noting that fHgz+1 |Bgz+1 ,Lgz1 ,V gzH,1,Cgz+0 (h1 | vH,1, b1, l1, 0) = I(h1 = g
−
z,H,1(l1, vB,1, vH,1)), and
fBgz+1 |Lgz1 ,V gzB,1,Cgz+0 (b1 | vB,1, l1, 0) = I(b1 = g
−
z,B,1(l1, vB,1)), so:
=
∑
l1
∑
h1
∑
b1
P (Y1 = 1 | C1 = 0, H1 = h1, B1 = b1, L1 = l1)
×
∫
vH,1
f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,V
gz
H,1
,C
gz+
0
(h1 | b1, l1, vH,1, 0)f(vH,1)
×
∫
vB,1
f
B
gz+
1 |L
gz
1 ,V
gz
B,1
,C
gz+
0
(b1 | l1, vB,1, 0)f(vB,1)
× P (L1 = l1)
And using the definition of stochastic regimes in expression (90),
=
∫
vB,1
∫
vH,1
∑
l1
∑
h1
∑
b1
P (Y1 = 1 | C1 = 0, H1 = h1, B1 = b1, L1 = l1)
× f
H
gz+
1 |B
gz+
1 ,L
gz
1 ,C
gz+
0
(h1 | b1, l1, 0)
× f
B
gz+
1 |L
gz
1 ,C
gz+
0
(b1 | l1, vB,1, 0)
× P (L1 = l1)
Now, all that is left is identifying the intervention distributions fBgz+1 |Lgz1 ,Cgz+0 (· | ·) and
fHgz+1 |Bgz+1 ,Lgz1 ,Cgz+0 (· | ·), which are defined in terms of factual distributions and user-specified
constraints, with the exception of marginal distributions of the natural values of treatment
and of treatment eligibility under regime gz. Both of these terms are identified using steps
analogous to the above, particularly employing weaker exchangeability conditions with re-
spect to Bgzk for Bk−1, Hk−1, and Ck−1, and with respect to H
gz
k for Bk, Hk−1, and Ck−1 of
expressions (94) - (99), respectively, as needed.
Then, we repeat for intervals k = 2, . . . , K and combine terms to yield E(Y gzK ) = f
gz
YK
(1),
with P (Bgzj = 1) = f
gz
Bj
(1), P (Hgzj = 1) = f
gz
Hj
(1), P (Rgzj = 1) = f
gz
Rj
(1), and P (Sgzj = 1) =
f gzSj (1).
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12. Appendix E: Equivalence of alternative g-formula representation
In this section we prove that the g-formula representations of expressions (25) and (28)
are equivalent, under the positivity conditions in expressions (23) and (24). We will rely on
the following Lemma.
Lemma 2.
E[(1− Yk−1)W gzH,kW gzB,k | V ] =
E[(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]− E[Yk−1(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]
where W gzB,k−1 and W
gz
H,k−1 are defined as in expressions (30) and (31), respectively.
Proof. First, given the positivity conditions (23) and (24), we have that
E[(1− Yk−1)W gzH,kW gzB,k | V ]
=E

(1− Yk−1)
×W gzH,k−1E
[
f
H
gz+
k
|Bgz+
k
,L
gz
k
,Y
gz
k−1,H
gz+
k−1
(Hk|Bk,Lk,0,Hk−1)
fHk|Bk,Lk,Yk−1,Hk−1 (Hk|Bk,Lk,0,Hk−1)
| Bk, Lk, Hk−1
]
×W gzB,k−1E
[
f
B
gz+
k
|Lgz
k
,Y
gz
k−1,H
gz+
k−1,B
gz+
k−1
(Bk|Lk,0,Hk−1,Bk−1)
fBk|Lk,Yk−1,Hk−1,Bk−1 (Bk|Lk,0,Hk−1,Bk−1)
| Lk, Hk−1, Bk−1
]
| V,

=E[(1− Yk−1)W gzH,k−1W gzB,k−1 | V ]
Since event Yk−1 = 0 implies joint event (Yk−1 = 0, Yk−2 = 0), then:
E[(1− Yk−1)W gzH,k−1W gzB,k−1 | V ]
=E[(1− Yk−1)(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]
=E[(1− Yk−2)W gzH,k−1W gzB,k−1 − Yk−1(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]
=E[(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]− E[Yk−1(1− Yk−2)W gzH,k−1W gzB,k−1 | V ]
Theorem 2. Define λgzY,k(V ) as in expression (29). It follows that the g-formula of expression
(25)
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∑
lK
∑
hK
∑
bK
K∑
k=1
P (Yk = 1 | Hk = hk, Bk = bk, Lk = lk, Yk−1 = 0)
×
k∏
j=1
{
f
Hgz+j |B
gz+
j ,L
gz
j ,Y
gz
j−1,H
gz+
j−1
(hj | bj, lj, 0, hj−1)
× f
Bgz+j |L
gz
j ,Y
gz
j−1,H
gz+
j−1 ,B
gz+
j−1
(bj | lj, 0, hj−1, bj−1)
× P (Lj = lj | Yj−1 = 0, Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1)
× P (Yj−1 = 0 | Hj−1 = hj−1, Bj−1 = bj−1, Lj−1 = lj−1, Yj−2 = 0)
}
,
is equivalent to the g-formula of expression (28)
∑
v
K∑
k=1
λgzY,k(v)
k−1∏
j=1
[1− λgzY,j(v)]f(v),
Proof. By definition of λgzY,k(V ), we can re-write the alternate g-formula expression of (28)
as
∑
v
K∑
k=1
E[Yk(1− Yk−1)W gzH,kW gzB,k | V = v]
×
k∏
j=1
E[(1− Yj−2)W gzH,j−1W gzB,j−1 | V = v]− E[Yj−1(1− Yj−2)W gzH,j−1W gzB,j−1 | V = v]
E[(1− Yj−1)W gzH,jW gzB,j | V = v]
f(v),
which by Lemma 2
=
∑
v
K∑
k=1
E[Yk(1− Yk−1)W gzH,kW gzB,k | V = v]f(v).
By laws of probability, and the positivity conditions (23) and (24), the last expression is
equivalent to the g-formula of (25).
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13. Appendix F: Extension to censoring
In Appendix D, we provide identification results in the general setting in which censor-
ing is present and in which our target estimands are expected potential outcomes under
proportionally-representative interventions for limited resources, under the ’natural course’;
that is, under an additional hypothetical intervention to prevent censoring in all individuals
(i.e. cK = 0). As in Appendix D consider Ck to be an indicator for censoring in interval k,
and a topological order within each interval of
(
Lk, Bk, Hk, Ck, Yk
)
. Also, as in Appendix
D redefine all regimes gz, z ∈ Z, to involve some proportionally-representative intervention,
and an intervention on C
gz
K such that C
gz+
K = 0 for all individuals.
In this setting, the constraints are specified as in expressions (60) and (62), and these
constraints motivate stochastic intervention distributions as in (68) and (69), except condi-
tional on being uncensored:
fBgz+k |Rgz+k ,Cgz+k ,L
gz
k
(1 | Rk, 0, Lk) =
(
αk(z, Rk)× fBk|Rk,Ck,Lk(1 | Rk, 0, Lk)
)igzB,k (114)
×(1− αk(z,Rk)× fBk|Rk,Ck,Lk(0 | Rk, 0, Lk))1−igzB,k ,
and
fHgz+k |Sgz+k ,Cgz+k ,L
gz
k
(1 | Sk, 0, Lk) =
(
βk(z, Sk)× fHk|Sk,Lk(1 | Sk, 0, Lk)
)igzH,k (115)
×(1− βk(z, Sk)× fHk|Sk,Ck,Lk(0 | Sk, 0, Lk))1−igzH,k ,
with αk(z,Rk) and βk(z, Sk) defined identically.
13.1. Identification
Identification conditions and subsequent g-formulae identification results are provided in
Appendix D.
13.1.1. Alternative g-formulae representation
As in the main text, the g-formula can be represented as in expression (28), except
λgzY,k(V ) is redefined to be
λgzY,k(V ) =
E
[
Yk(1− Yk−1)W gzH,kW gzB,kW gzC,k | V
]
E
[
(1− Yk−1)W gzH,kW gzB,kW gzC,k | V
] , (116)
where W gzB,k and W
gz
H,k are redefined conditional on censoring, as in:
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WB,k(Z) =
k∏
j=1

((
αj(Z,Rj)×fBj |Rj,Cj−1,Lj (1|Rj ,Cj−1,Lj)
)Bj
×
(
1−αj(Z,Rj)×fBj |Rj,Cj−1,Lj (1|Rj ,Cj−1,Lj)
)1−Bj
fBj |Rj,Cj−1,Lj (Bj |Rj ,Cj−1,Lj)
)iB,k(Z)
×
((
1−αj(Z,Rj)×fBj |Rj,Cj−1,Lj (0|Rj ,Cj−1,Lj)
)Bj
×
(
αj(Z,Rj)×fBj |Rj,Cj−1,Lj (0|Rj ,Cj−1,Lj)
)1−Bj
fBj |Rj,Cj−1,Lj (Bj |Rj ,Cj−1,Lj)
)(1−iB,k(Z))
 .
(117)
and
WH,k(Z) =
k∏
j=1

((
βj(Z,Sj)×fHj |Sj,Cj−1,Lj (1|Sj ,Cj−1,Lj)
)Hj
×
(
1−βj(Z,Sj)×fHj |Sj,Cj−1,Lj (1|Sj ,Cj−1,Lj)
)1−Hj
fHj |Sj,Cj−1,Lj (Hj |Sj ,Cj−1,Lj)
)iH,k(Z)
×
((
1−βj(Z,Sj)×fHj |Sj,Cj−1,Lj (0|Sj ,Cj−1,Lj)
)Hj
×
(
βj(Z,Sj)×fHj |Sj,Cj−1,Lj (0|Sj ,Cj−1,Lj)
)1−Hj
fHj |Sj,Cj−1,Lj (Hj |Sj ,Cj−1,Lj)
)(1−iH,k(Z))
 .
(118)
and W gzC,k is defined as
W gzC,k =
k∏
j=1
I(Cj = 0)
fCj |Hj ,Sj ,Lj ,Cj−1(Cj | Hj, Sj, Lj, Cj−1)
. (119)
The g-formulae for Bk and Hk are expressed identically as in (32) and (34), and the
additional g-formulae for Rk and Sk as in (79) and (81), except all densities condition on
being uncensored.
13.2. Inverse Probability Weighted Estimation of Risk under Proportionally Representative
Interventions
13.2.1. Marginal Structural Models
Consider a cloned dataset as in the subsection 8.3.1 of Appendix A. Then λgzY,k(V ), is
analagously expressed as in (36), with WB,k(Z) and WH,k(Z) analagously redefined as in
(77) and (78). The intervention to abolish censoring is invariant across regimes indexed by
z, so the weight is not redefined. The MSM is specified identically as in Appendix A.
13.2.2. Inverse Probability Weighted Estimation
Let ψˆ be the solution to the estimating equation
n∑
i=1
∑
z
K∑
k=1
Ui,k(ψ, ηˆB, ηˆH , ηˆC), (120)
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,
with respect to ψ, where
Uk(ψ, ηˆB, ηˆH , ηˆC) =[Yk − h{γ(k, Z, V ;ψ)}] (121)
× (1− Yk−1)WB,k(Z, ηˆB)WH,k(Z, ηˆH)W gzC,k(ηˆC).
Estimated weights WB,k(Z, ηˆB), WH,k(Z, ηˆH), and W
gz
C,k(ηˆC), and their components are
defined to those in Appendix A, swapping parameters models of conditional treatment
and censoring with there estimated counterparts. Estimators for pˆiB,j(Z, ηˆ) and pˆiH,j(Z, ηˆ),
pˆiR,j(Z, ηˆ), and pˆiS,j(Z, ηˆ) are defined analogously as in Section 8.3.2, except by additionally
weighting by estimated censoring weights, For example,
pˆiB,j(Z, ηˆ) =
1
n
n∑
i=1
[
Bi,jWH,i,j−1(Zi, ηˆ)WB,i,j−1(Zi, ηˆ)W
gz
C,i,j−1(ηˆ)
]
. (122)
Then, as in Section 8.3.1, if (i) the MSM is correctly specified; and (ii), the models
fBj |Rj ,Cj−1,Lj(Bj | Rj, Cj−1, Lj; ηB), fHj |Sj ,Cj−1,Lj(Hj | Sj, Cj−1, Lj; ηH), and fCj |Hj ,Sj ,Lj ,Cj−1(Cj |
Hj, Sj, Lj, Cj−1; ηC) are correctly specified, then we have
E[Uk(ψ∗, η∗B, η∗H , η∗C)] = 0 (123)
for all k, with η∗B, η
∗
H , and η
∗
C the true values of ηB, ηH , and ηC and the IPW estimator
ψˆ consistent and asymptotically normal for ψ∗.
Here, we assume pooled logistic models for fBk|Rk,Ck−1,Lk(Bk | 1, 0, Lk; ηB) and fHk|Sk,Ck−1,Lk(Hk |
1, 0, Lk; ηH), and fCk|Hk,Sk,Ck−1,Lk(Ck | 0, 1, 0, Lk; ηC), that is,
fBk|Rk,Ck−1,Lk(Bk | 1, 0, Lk; ηB) = expit{φB(k, Lk; ηB)} (124)
and
fHk|Sk,Ck−1,Lk(Hk | 1, 0, Lk; ηH) = expit{φH(k, Lk; ηH)} (125)
and
fCk|Hk,Sk,Ck−1,Lk(Ck | 0, 1, 0, Lk; ηC) = expit{φC(k, Lk; ηC)} (126)
with φB, φH , and φC specified functions of (k, Lk), differentiable with respect to ηB,
ηH , and ηC . Note that fBk|Rk,Ck−1,Lj(0 | 0, 0, Lk; ηB) = fHk|Sk,Ck−1,Lj(0 | 0, 0, Lk; ηH) = 1 by
definition (that is, previously treated or deceased uncensored individuals will be untreated
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in interval k, with probability 1). Further, note that fBk|Rk,Ck−1,Lj(0 | Rk, 1, Lk; ηB) =
fHk|Sk,Ck−1,Lj(0 | Sk, 1, Lk; ηB) = fCk|Hk,Sk,Ck−1,Lk(1 | 0, Sk, 1, Lk; ηC) = 1 by definition (that
is, censored individuals will be untreated and stay censored in interval k with probability
1). Finally, note that fCk|Hk,Sk,Ck−1,Lk(0 | 0, 0, 0, Lk; ηC) = 1 in this particular setting (that
is, previously treated or deceased uncensored individuals will remain uncensored in interval
k, with probability 1). This last quality of the conditional censoring density is particular to
the study in the applied example, where previously treated individuals will never be treated
again, and where the only other time-varying variable after treatment is death, which is
measured with 100% reliability.
Assuming the same model for h{γ(k, Z, V ;ψ)} as in the main text, we can solve the
estimating equation with the following generalized algorithm, applied to a cloned subject-
interval dataset, constructed as in section 8.3.2:
Generalized IPW estimation algorithm for ψ
1. Using subject-interval records with Z = 1 and Rk = 1 and Ck = 0, obtain ηˆB by fitting
pooled logistic regression model (124) with dependent variable Bk and independent
variables a specified function of k = 0, . . . , K and Lk, corresponding to the choice of
φB(·).
2. Using subject-interval records with Z = 1 and Sk = 1 and Ck = 0, obtain ηˆH by fitting
a pooled logistic regression model (125) with dependent variable Hk and independent
variables a specified function of k = 0, . . . , K and Lk, corresponding to the choice of
φH(·).
3. Using subject-interval records with Z = 1 and Sk = 1 and Hk = 0 and Ck−1 = 0, obtain
ηˆC by fitting a pooled logistic regression model (126) with dependent variable Ck and
independent variables a specified function of k = 0, . . . , K and Lk, corresponding to
the choice of φC(·).
4. For each subject’s line k, attach the suspected-superior treatment weight, WC,k, cal-
culated as:
k∏
j=1
1
1− expit{φC(j, Lj; ηˆC)}
5. For all z ∈ Z, r1 ∈ {0, 1}, set α0(z, r0, ηˆ) and β0(z, s0, ηˆ) to 1. Obtain α1(z, r1, ηˆ),
ℵB,1(z), and iB,1(z) by evaluating the estimated analogues of expression (70), (64), and
(66), noting that P (Bgz+1 = 1) is defined by the intervention, and taking pˆiB,1(z, ηˆ) to be
the proportion of individuals with B1 = 1,
1
n
∑n
i=1Bi,1, and noting that pˆiR,1(z, ηˆ) = 1
by definition.
6. For each subject’s line 1, attach the suspected-superior treatment weight, WB,1, cal-
culated as:
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
(α1(Z,R1)×expit{φB(1,L1;ηˆB)})B1×(1−αj(Z,R1)×expit{φB(1,L1;ηˆB)})1−B1(
expit{φB(1,L1;ηˆB)}
)B1
×
(
1−expit{φB(1,L1;ηˆB)}
)1−B1
iB,1(Z)
×
(1−α1(Z,R1)×(1−expit{φB(1,L1;ηˆB)}))B1×(αj(Z,R1)×(1−expit{φB(1,L1;ηˆB)}))1−B1(
expit{φB(1,L1;ηˆB)}
)B1
×
(
1−expit{φB(1,L1;ηˆB)}
)1−B1
(1−iB,1(Z))

.
7. For all z ∈ Z, s1 ∈ {0, 1}, then obtain β1(z, s1, ηˆ), ℵH,1(z), and iH,1(z).
8. For each subject’s line 1, attach the suspected-inferior treatment weight, WH,1, calcu-
lated as:

(β1(Z,S1)×expit{φH(1,L1;ηˆH)})H1×(1−β1(Z,S1)×expit{φH(1,L1;ηˆH)})1−H1(
expit{φH(1,L1;ηˆH)}Big)H1×
(
1−expit{φH(1,L1;ηˆH)}
)1−H1
iH,1(Z)
×
(1−β1(Z,S1)×(1−expit{φH(1,L1;ηˆH)}))B1×(β1(Z,S1)×(1−expit{φH(1,L1;ηˆH)}))1−H1(
expit{φH(1,L1;ηˆH)}
)H1
×
(
1−expit{φH(1,L1;ηˆH)}
)1−H1
(1−iH,1(Z))

.
9. Iterate from k = 2, . . . K:
9.1. For all z ∈ Z, rk ∈ {0, 1}, obtain αk(z, rk, ηˆ), ℵB,k(z), and iB,k(z).
9.2. Using subject-interval records on line k, attach the suspected-superior treatment
weight, WB,k, calculated as:
k∏
j=1

(αj(Z,Rj)×expit{φB(j,Lj ;ηˆB)})Bj×(1−αj(Z,Rj)×expit{φB(j,Lj ;ηˆB)})1−Bj(
expit{φB(j,Lj ;ηˆB)}
)Bj
×
(
1−expit{φB(j,Lj ;ηˆB)}
)1−Bj
iB,j(Z)
×
(j−αj(Z,Rj)×(1−expit{φB(j,Lj ;ηˆB)}))Bj×(αj(Z,Rj)×(1−expit{φB(j,Lj ;ηˆB)}))1−Bj(
expit{φB(j,Lj ;ηˆB)}
)Bj
×
(
1−expit{φB(j,Lj ;ηˆB)}
)1−Bj
(1−iB,j(Z))

.
9.3. For all z ∈ Z, sk ∈ {0, 1}, obtain βk(z, sk, ηˆ), ℵH,k(z), and iH,k(z).
9.4. Using subject-interval records on line k with Z = z, attach the suspected-superior
treatment weight, WH,k, calculated as:
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k∏
j=1

(βj(Z,Sj)×expit{φH(j,Lj ;ηˆH)})Hj×(1−βj(Z,Sj)×expit{φH(j,Lj ;ηˆH)})1−Hj(
expit{φH(j,Lj ;ηˆH)}Big)Hj×
(
1−expit{φH(j,Lj ;ηˆH)}
)1−Hj
iH,j(Z)
×
(j−βj(Z,Sj)×(1−expit{φH(j,Lj ;ηˆH)}))Bj×(βj(Z,Sj)×(1−expit{φH(j,Lj ;ηˆH)}))1−Hj(
expit{φH(j,Lj ;ηˆH)}
)Hj
×
(
1−expit{φH(j,Lj ;ηˆH)}
)1−Hj
(1−iH,j(Z))

.
10. Using all subject-interval records in the cloned dataset, obtain ψˆ by fitting a weighted
pooled logistic regression model, with weights WB,k and WH,k and WC,k defined in the
previous steps, dependent variable Yk and independent variables a specified function
of k = 1, . . . , K and (Z, V ) corresponding to the choice of γ(·).
Our final IPW estimate of the g-formula for the risk of death byK under regime gz, f
gz
YK
(1)
defined by the arbitrary proportionally-representative interventions that constrain resources
under the natural course can then be obtained by the plug-in estimator of expression (56)
in the main text.
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14. Appendix G: Model specifications in Data Analysis
In constructing the denominator of the weights, we assumed that
φB(k, Lk; ηB) = ηB,0 + η
T
B,1g(k) + φ
∼(k, Lk : η∼B), (127)
where g(k) is specified as a natural cubic spline function with internal knots at ξI =
(2, 4, 12, 24, 54), boundary knots at ξB = (1, 120), and truncated power basis functions
tI(k, ξI) =
{
(k − ξI)3 if k > ξI
0 otherwise.
}
, and tB(k, ξB) =
{
(k − ξB) if k > ξB
0 otherwise.
}
:
g(k) = {k, k2, K3, tI(k, ξI,1), . . . , tI(k, ξI,5), tB(k, ξB,1), tB(k, ξB,2)}, (128)
and assumed
φH(k, Lk; ηH) = ηH,0 + η
T
H,1g(k) + φ
∼(k, Lk : η∼H). (129)
.
Further, since all regimes involved interventions to abolish censoring, we constructed
censoring weights, and, as such, specified censoring models, where
φC(k, Lk; ηC) = ηC,0 + η
T
C,1g(k) + φ
∼(k, Lk : η∼C ). (130)
The functional form of φ∼(·) is common across treatment and censoring models and
consists of the product of a model-specific vector of parameters with a vector of features
defined by Lk. When k = 1, these features are defined in Table 1, where categorical features
are transformed into a subvector of dummy variables, and where continuous features are
specified as natural cubic splines with internal knots at their 35th and 65th percentiles, and
boundary knots at their 5th and 95th percentiles, parameterized analagous to g(k) above.
Time varying features include MELD score, specified as a natural cubic spline function iden-
tically to other continuous variables, and an interaction between Baseline MELD exception
status and g(k).
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Table 1: Table of Baseline Covariates
Variable Values
Baseline MELD Continuous
Baseline MELD exception Yes/No
Status 1 Yes/No
Gender Male/Female
Race (categorical) Pacific Islander
Hispanic or Latino
Asian
Black or African American
Native American
White
Multi-Racial
Year of Listing (categorical) 2005-2015
Age (years) Continuous
Height (cm) Continuous
Weight (kg) Continuous
Willingness to...
Accept Incompatible Blood Type Yes/No
Accept Extra Corporeal Liver Yes/No
Accept Liver Segment Yes/No
Accept HBV Positive Donor Yes/No
Accept HCV Positive Donor Yes/No
Patient On Life Support Yes/No
Functional Status (categorical) Requires No Assistance
Some assistance
Total assistance
Primary Diagnosis (categorical) Cholestatic
Fulminant Hepatic Failure
Malignant Neoplasm
Metabolic
Non-cholestatic/Other
Spontaneous Bacterial Peritonitis Yes/No
History of Portal Vein Thrombosis Yes/No
History of TIPSS Yes/No
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